Thomas Felix Lüscher

Thomas Felix Lüscher's AcademicInfluence.com Rankings

Medical

#341

World Rank

#488

Historical Rank

Cardiology

World Rank

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Thomas Felix Lüscher Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Thomas Felix Lüscher's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension (2003) (2640)
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I (2003) (2007)
Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. (1995) (1713)
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. (2015) (1708)
Ferric carboxymaltose in patients with heart failure and iron deficiency. (2009) (1586)
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. (1990) (1121)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). (2014) (983)
The Assessment of Endothelial Function: From Research Into Clinical Practice (2012) (940)
Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications (2007) (917)
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. (1986) (912)
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. (1990) (865)
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology (2018) (855)
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial (2007) (781)
High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. (1997) (769)
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. (2005) (719)
Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance: A Comparison With Positron Emission Tomography and Coronary Angiography (2001) (699)
Acute heart transplant rejection due to Saint John's wort (2000) (690)
Enhanced Peroxynitrite Formation Is Associated with Vascular Aging (2000) (669)
Therapeutic Implications (2020) (657)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. (2005) (607)
The Endothelium: Modulator of Cardiovascular Function (1990) (603)
Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. (1997) (598)
Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs (2000) (597)
COVID-19 is, in the end, an endothelial disease (2020) (594)
Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. (1988) (548)
Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. (1994) (545)
Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis (2002) (529)
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. (2011) (522)
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. (1996) (499)
Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? (1990) (473)
Anti-inflammatory therapies for cardiovascular disease. (2014) (467)
High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men (2002) (464)
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications (2006) (457)
High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells: Role of Protein Kinase C and Reactive Oxygen Species (2003) (456)
International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management (2018) (451)
Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. (1987) (416)
Cocoa and Cardiovascular Health (2009) (403)
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. (1998) (394)
Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. (2014) (377)
Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. (1998) (377)
Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. (1992) (376)
Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol (2016) (366)
Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. (1998) (365)
Statin Prevents Tissue Factor Expression in Human Endothelial Cells: Role of Rho/Rho-Kinase and Akt Pathways (2002) (359)
Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66shc Gene (2006) (357)
Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. (1991) (347)
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels. (2017) (339)
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors (2017) (338)
Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. (1995) (333)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. (2016) (331)
Atherosclerosis and the two faces of endothelial nitric oxide synthase. (1998) (331)
Arterial fibromuscular dysplasia. (1987) (331)
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial (2004) (329)
Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist. (1997) (328)
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. (1997) (324)
Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. (1990) (322)
Endothelium-derived contracting factors. (1992) (320)
Mental Stress Induces Prolonged Endothelial Dysfunction via Endothelin-A Receptors (2002) (319)
The Esc Textbook of Cardiovascular Medicine (2009) (317)
Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. (2013) (315)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of High-Density Lipoprotein–Proteome Remodeling (2013) (313)
Selective COX-2 Inhibition Improves Endothelial Function in Coronary Artery Disease (2003) (311)
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. (2012) (311)
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. (2002) (310)
Vasopeptidase Inhibitors: A New Therapeutic Concept in Cardiovascular Disease? (2001) (303)
Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. (1995) (300)
The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. (2014) (299)
Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. (1996) (297)
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis (2018) (289)
Deletion of p66shc Gene Protects Against Age-Related Endothelial Dysfunction (2003) (284)
Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis (2004) (281)
Nitric Oxide in Hypertension (2006) (280)
Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. (1992) (274)
Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock: Results of the Impella–EUROSHOCK-Registry (2013) (273)
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. (2000) (272)
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. (1990) (268)
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein (2005) (267)
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. (2001) (267)
Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? (1990) (262)
Assessment of atherosclerosis: the role of flow-mediated dilatation. (2010) (261)
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. (2013) (256)
Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. (1996) (255)
Endothelial dysfunction in coronary artery disease. (1993) (255)
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. (2013) (252)
High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. (2014) (252)
Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. (1997) (245)
Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function (2000) (241)
A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction (2013) (240)
Biology of the Endothelium (1997) (237)
Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. (1992) (236)
Hemodynamic and Neurohumoral Effects of Selective Endothelin A (ETA) Receptor Blockade in Chronic Heart Failure: The Heart Failure ETA Receptor Blockade Trial (HEAT) (2002) (236)
Coffee Acutely Increases Sympathetic Nerve Activity and Blood Pressure Independently of Caffeine Content: Role of Habitual Versus Nonhabitual Drinking (2002) (230)
Dark Chocolate Improves Coronary Vasomotion and Reduces Platelet Reactivity (2007) (228)
Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. (1991) (226)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial (2014) (221)
Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. (2000) (220)
Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. (2012) (219)
Pulsatile stretch stimulates superoxide production and activates nuclear factor-kappa B in human coronary smooth muscle. (1997) (217)
Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. (1990) (215)
Gene Silencing of the Mitochondrial Adaptor p66Shc Suppresses Vascular Hyperglycemic Memory in Diabetes (2012) (212)
Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress (2007) (210)
Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. (2004) (210)
Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. (1991) (208)
Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. (2000) (207)
The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? (1994) (206)
Connective tissue growth factor. Friend or foe? (1997) (202)
Endothelial control of vascular tone in large and small coronary arteries. (1990) (201)
Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. (1996) (199)
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease (2012) (199)
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis (2009) (197)
Differences in the Clinical Profile and Outcomes of Typical and Atypical Takotsubo Syndrome: Data From the International Takotsubo Registry. (2016) (196)
Pulsatile stretch stimulates superoxide production in human aortic endothelial cells. (1997) (196)
Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction: Effects on Global Left Ventricular Function (2013) (193)
Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries. (2009) (192)
Impaired Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Prehypertension: Relation to Endothelial Dysfunction (2010) (192)
Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. (2000) (188)
Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7* (1999) (185)
Electrocardiographically gated multi-detector row CT for assessment of valvular morphology and calcification in aortic stenosis. (2002) (184)
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia (2018) (183)
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. (2007) (183)
Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). (2011) (181)
Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin Regulation (1997) (181)
Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. (2008) (178)
Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial (2011) (178)
Dark chocolate improves endothelial and platelet function (2005) (178)
Thrombin Suppresses Endothelial Nitric Oxide Synthase and Upregulates Endothelin-Converting Enzyme-1 Expression by Distinct Pathways: Role of Rho/ROCK and Mitogen-Activated Protein Kinase (2001) (177)
ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension (1998) (176)
Tetrahydrobiopterin and endothelial nitric oxide synthase activity. (1999) (175)
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. (2015) (175)
Reactive Oxygen Species Mediate Endothelium-Dependent Relaxations in Tetrahydrobiopterin-Deficient Mice (2001) (175)
Characterization of Dysfunctional Myocardium by Positron Emission Tomography and Magnetic Resonance: Relation to Functional Outcome After Revascularization (2003) (174)
Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease. (2015) (174)
AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. (2013) (173)
Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? (2003) (173)
Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression: Implications for Drug-Eluting Stent Design (2005) (171)
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. (2015) (170)
Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter (2013) (168)
Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade. (1999) (167)
Transplantation and Tracking of Human-Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment, and Distribution by Hybrid Single Photon Emission Computed Tomography/Computed Tomography of Sodium Iodide Symporter Transgene Expression (2012) (164)
Long-Term Prognosis of Patients With Takotsubo Syndrome. (2018) (164)
Effects of chronic ETA-receptor blockade in angiotensin II-induced hypertension. (1997) (161)
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk (2016) (159)
Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. (2012) (159)
Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. (2007) (157)
Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease (2010) (156)
The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. (1995) (154)
Endothelium-dependent regulation of the ophthalmic microcirculation in the perfused porcine eye: role of nitric oxide and endothelins. (1993) (153)
Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes (1995) (152)
SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. (2011) (150)
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? (2001) (149)
Potential role of endothelin in hypertension. Controversy on endothelin in hypertension. (1993) (147)
Magnetic resonance-based assessment of global coronary flow and flow reserve and its relation to left ventricular functional parameters: a comparison with positron emission tomography. (2000) (147)
Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. (2010) (146)
SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice (2010) (146)
Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. (1997) (145)
Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle (1992) (144)
Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease (2018) (144)
Happy heart syndrome: role of positive emotional stress in takotsubo syndrome (2016) (142)
The endothelium and cardiovascular disease--a complex relation. (1994) (141)
Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. (1994) (141)
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study (2012) (141)
Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry (2013) (139)
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease (2007) (139)
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial (2013) (138)
Endothelial dysfunction in diabetes mellitus. (1998) (137)
Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. (1998) (137)
Histamine Induces Tissue Factor Expression Implications for Acute Coronary Syndromes (2005) (137)
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia (2007) (136)
Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. (2000) (136)
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. (2003) (135)
Compliance in hypertension: facts and concepts. (1985) (135)
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes. (2015) (135)
Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report (2002) (134)
A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry (2017) (132)
Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. (1995) (131)
Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. (1993) (128)
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity (2013) (126)
Endothelial regulation of vascular tone and growth. (1993) (126)
Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy (2010) (124)
MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. (2016) (124)
Targeting cardiovascular inflammation: next steps in clinical translation. (2020) (124)
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. (2009) (123)
ECG Criteria to Differentiate Between Takotsubo (Stress) Cardiomyopathy and Myocardial Infarction (2016) (123)
Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade. (1997) (123)
Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure (2000) (123)
The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression (2014) (121)
L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil. (1995) (121)
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration (2017) (121)
Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome (2019) (121)
Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. (2011) (121)
Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels (2017) (120)
Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Endothelial Function in Salt-Induced Hypertension (2003) (120)
Paclitaxel Enhances Thrombin-Induced Endothelial Tissue Factor Expression via c-Jun Terminal NH2 Kinase Activation (2006) (119)
Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus (2015) (119)
Endothelium-dependent regulation of vascular tone of the porcine ophthalmic artery. (1991) (118)
Loss of AngiomiR-126 and 130a in Angiogenic Early Outgrowth Cells From Patients With Chronic Heart Failure: Role for Impaired In Vivo Neovascularization and Cardiac Repair Capacity (2012) (118)
Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. (1990) (117)
Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. (1993) (116)
Septicemia Caused by Tick-borne Bacterial Pathogen Candidatus Neoehrlichia mikurensis (2010) (116)
Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin (2004) (115)
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II (2003) (115)
Global position paper on cardiovascular regenerative medicine (2017) (115)
Carbamylated low-density lipoprotein induces endothelial dysfunction. (2014) (115)
Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. (1986) (115)
Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH2 Kinase Phosphorylation (2005) (114)
Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia (2009) (114)
Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. (1998) (114)
Simvastatin improves endothelial function in patients with rheumatoid arthritis. (2005) (114)
Cardiovascular disease in HIV infection. (2006) (113)
Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy. (2017) (113)
Effects of Tacrolimus or Sirolimus on Proliferation of Vascular Smooth Muscle and Endothelial Cells (2006) (112)
Prognostic value of PCSK9 levels in patients with acute coronary syndromes. (2016) (112)
18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo (2005) (112)
The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry Monitoring. (2016) (112)
HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins. (2000) (112)
Cell-Type-Specific Characteristics Modulate the Transduction Efficiency of Adeno-Associated Virus Type 2 and Restrain Infection of Endothelial Cells (2002) (111)
Endothelium-derived relaxing and contracting factors: perspectives in nephrology. (1991) (111)
Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy (2009) (110)
Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. (1991) (110)
Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease (1993) (110)
Endothelium-dependent contractions. (1991) (110)
Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization. (2006) (110)
Cyclosporin A increases nitric oxide activity in vivo. (1997) (109)
Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. (2012) (109)
Cardiovascular effects of flavanol-rich chocolate in patients with heart failure. (2012) (108)
Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases. (2010) (108)
Selective Inhibition of Protein Kinase Cβ2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells (2004) (108)
Angiotensin Blockade or Calcium Antagonists Improve Endothelial Dysfunction in Hypertension: Studies in Perfused Mesenteric Resistance Arteries (1994) (107)
Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis. (2000) (107)
Accuracy of smartphone apps for heart rate measurement (2017) (106)
Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. (2011) (106)
Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. (1993) (106)
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata (2011) (106)
Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat. (1990) (105)
Human endothelial dysfunction: EDRFs (2010) (105)
Twenty-four-hour secretory pattern of cortisol in the bull: evidence of episodic secretion and circadian rhythm. (1981) (104)
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. (2018) (104)
Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: role of blood pressure and endothelial function. (1998) (103)
Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. (1999) (102)
Hypoxia enhances lipid uptake in macrophages: role of the scavenger receptors Lox1, SRA, and CD36. (2013) (102)
Endothelium-dependent Vasoactive Modulation in the Ophthalmic Circulation (2001) (102)
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes (2016) (101)
Rapid and Body Weight–Independent Improvement of Endothelial and High-Density Lipoprotein Function After Roux-en-Y Gastric Bypass: Role of Glucagon-Like Peptide-1 (2015) (101)
The endothelium as a target and mediator of cardiovascular disease (1993) (101)
Molecular and cellular biology of endothelin and its receptors--Part I. (1993) (100)
Different interactions of platelets with arterial and venous coronary bypass vessels (1991) (100)
Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents (2006) (99)
The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study (2010) (98)
Real-Time Left Ventricular Pressure-Volume Loops During Percutaneous Mitral Valve Repair With the MitraClip System (2013) (98)
Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein. (1989) (98)
Mouse Models for Atherosclerosis Research—Which Is My Line? (2019) (97)
Reduced Connexin43 Expression Limits Neointima Formation After Balloon Distension Injury in Hypercholesterolemic Mice (2006) (96)
Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome (2017) (95)
Endothelial Vasoactive Substances and Cardiovascular Disease (1988) (95)
High Potassium Diet Augments Endothelium‐Dependent Relaxations in the Dahl Rat (1988) (95)
Endothelium-dependent relaxations in human arteries. (1987) (94)
Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. (2010) (94)
Degenerative Aortic Valve Stenosis, but not Coronary Disease, Is Associated With Shorter Telomere Length in the Elderly (2006) (93)
Novel findings in neutrophil biology and their impact on cardiovascular disease. (2019) (93)
ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. (1998) (93)
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future (2017) (93)
Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. (1997) (92)
Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. (1996) (92)
c-Jun N-Terminal Kinase 2 Deficiency Protects Against Hypercholesterolemia-Induced Endothelial Dysfunction and Oxidative Stress (2008) (91)
Structure and reactivity of small arteries in aging. (1998) (91)
Deletion of the Activated Protein-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates Age-Related Endothelial Dysfunction (2013) (91)
Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat. (1992) (89)
Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). (2010) (89)
Tissue Factor and Cardiovascular Disease (2010) (89)
Transforming growth factor-&bgr;-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis (2016) (89)
Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy. (2012) (89)
Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. (2017) (88)
Takotsubo cardiomyopathy: still much more to learn (2014) (88)
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study† (2009) (88)
Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension (2007) (88)
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. (2013) (87)
Endothelium‐Dependent Regulation of Resistance Arteries: Alterations with Aging and Hypertension (1992) (87)
Alterations to the nitric oxide pathway in the spontaneously hypertensive rat (1998) (87)
Pharmacological approaches to improve endothelial repair mechanisms (2008) (87)
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. (2010) (87)
Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin (1995) (86)
Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location. (2012) (86)
Aging differentially affects direct and indirect actions of endothelin‐1 in perfused mesenteric arteries of the rat (1990) (86)
Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension. (1982) (86)
Tetrahydrobiopterin and endothelial function. (1998) (85)
Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction (2016) (84)
Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. (2012) (84)
Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis--implications for cardiovascular safety. (2013) (84)
Fibroblast Growth Factor-2, But Not Vascular Endothelial Growth Factor, Upregulates Telomerase Activity in Human Endothelial Cells (2003) (84)
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. (2007) (84)
Heterogeneity of endothelial dysfunction in hypertension. (1992) (83)
Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics. (1997) (83)
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) (2014) (83)
Torcetrapib impairs endothelial function in hypertension. (2012) (82)
Aldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced Hypertension (2001) (82)
Endothelin receptor antagonists inhibit endothelin in human skin microcirculation. (1994) (82)
Endothelial function as an end-point in interventional trials: concepts, methods and current data (1996) (81)
Blood pressure and vascular effects of endothelin blockade in chronic nitric oxide-deficient hypertension. (1997) (81)
Oxidized Low-Density Lipoprotein Activates p66Shc via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Protein Kinase C-&bgr;, and c-Jun N-Terminal Kinase Kinase in Human Endothelial Cells (2011) (81)
From abstract to impact in cardiovascular research: factors predicting publication and citation (2012) (80)
Endothelium‐Derived Vasoactive Substances: Potential Role in Hypertension, Atherosclerosis, and Vascular Occlusion (1989) (80)
Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial. (2016) (80)
Different Mobilization of Calcium in Endothelin‐1 -Induced Contractions in Human Arteries and Veins: Effects of Calcium Antagonists (1990) (79)
Different Prognostic Value of Functional Right Ventricular Parameters in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (2014) (79)
17β-Estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males (1996) (79)
Variability and reproducibility of flow-mediated dilatation in a multicentre clinical trial. (2013) (79)
Erythropoietin‐induced excessive erythrocytosis activates the tissue endothelin system in mice (2003) (78)
Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans. (1995) (78)
Retinal microvascular dysfunction in heart failure (2018) (77)
The vascular endothelium in hypertension. (2006) (77)
Progression of aortic stenosis. Role of age and concomitant coronary artery disease. (1993) (77)
Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome (2021) (76)
Dysfunctional Baroreflex Regulation of Sympathetic Nerve Activity in Patients With Vasovagal Syncope (2003) (76)
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. (2008) (76)
Long-term experience in percutaneous transluminal dilatation of renal artery stenosis. (1985) (76)
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial (2005) (76)
Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins. (1995) (75)
Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. (2009) (75)
Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes. (2015) (75)
Renal nerve ablation after SYMPLICITY HTN-3: confused at the higher level? (2014) (75)
Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses: a potential gatekeeper for coronary revascularization? (2009) (74)
Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients With Low Left Ventricular Ejection Fraction. (2017) (74)
Working under pressure: the vascular endothelium in arterial hypertension (2000) (73)
Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta. (1991) (73)
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial (2017) (72)
PCSK9 and inflammation: Role of shear stress, pro-inflammatory cytokines and LOX-1 4. (2019) (72)
Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. (2014) (71)
Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions (1996) (71)
ETA Receptors Mediate Vasoconstriction of Large Conduit Arteries During Reduced Flow in Humans (2003) (71)
Nasal oxygen and muscle sympathetic nerve activity in heart failure. (2003) (71)
Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury. (2013) (71)
Vulnerable plaques and patients: state-of-the-art. (2020) (71)
Histamine H1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins (2010) (71)
Protection of Endothelial Function: Targets for Nutritional and Pharmacological Interventions (2006) (71)
Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists. (1995) (70)
The endothelium. Target and promoter of hypertension? (1990) (70)
Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure. (1997) (70)
Coronary Microvascular Dysfunction Induced by Primary Hyperparathyroidism is Restored After Parathyroidectomy (2012) (70)
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus (2022) (69)
SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory (2013) (69)
Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging. (2011) (69)
Decreased plasma and tissue levels of vitamin C in a rat model of aging: implications for antioxidative defense. (2003) (69)
PARP1 is required for adhesion molecule expression in atherogenesis. (2007) (69)
Pacing in magnetic resonance imaging environment: clinical and technical considerations on compatibility. (2001) (69)
Expression of nitric oxide synthase isoforms in the thyroid gland: evidence for a role of nitric oxide in vascular control during goiter formation. (1995) (69)
Tissue factor and cardiovascular disease: quo vadis? (2010) (68)
Impact of cardiac hybrid single-photon emission computed tomography/computed tomography imaging on choice of treatment strategy in coronary artery disease (2011) (68)
Statins and the Risk of Cancer After Heart Transplantation (2012) (68)
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. (2019) (67)
Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. (1997) (67)
Age-Related Changes in Vascular Smooth Muscle and Endothelium (1995) (67)
Levels and Determinants of Inflammatory Biomarkers in a Swiss Population-Based Sample (CoLaus Study) (2011) (67)
SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together. (2013) (67)
Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. (2013) (66)
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score (2018) (66)
Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective. (2013) (66)
Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? (2001) (66)
Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results. (2016) (66)
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin (2014) (65)
Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake. (2020) (65)
Endothelial function and sympathetic nervous system activity in patients with Takotsubo syndrome. (2016) (65)
Electrocardiographic changes in early recognition of Fabry disease (2011) (65)
Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction. (2010) (65)
Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation (2011) (64)
Renal denervation: symply trapped by complexity? (2015) (64)
Mechanical versus manual chest compression CPR under ground ambulance transport conditions (2013) (64)
Renovascular hypertension impairs formation of endothelium‐derived relaxing factors and sensitivity to endothelin‐1 in resistance arteries (1991) (64)
I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. (1998) (63)
Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries. (1998) (63)
Takotsubo Syndrome Associated With Structural Brain Alterations of the Limbic System. (2018) (63)
Simple renal cyst and hypertension: cause or coincidence? (1986) (63)
Is takotsubo syndrome a microvascular acute coronary syndrome? Towards of a new definition. (2016) (62)
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease (2017) (62)
Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure. (2018) (62)
Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke. (2015) (62)
Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol. (2006) (62)
Vascular Protective Effects of Angiotensin Converting Enzyme Inhibitors and their Relation to Clinical Events (2001) (62)
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. (2010) (61)
Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments. (2011) (61)
Cardiac CT and echocardiographic evaluation of peri‐device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device (2015) (61)
Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. (1996) (61)
Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry (2019) (61)
Nitric oxide in cardiovascular diseases. (1995) (61)
Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2. (1994) (61)
Association between Inflammatory and Obesity Markers in a Swiss Population-Based Sample (CoLaus Study) (2012) (61)
Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. (1989) (61)
Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads. (1999) (60)
Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. (2017) (60)
Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. (2005) (60)
A Novel Circulating MicroRNA for the Detection of Acute Myocarditis. (2021) (60)
Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome (2014) (60)
Dietary &agr;-Linolenic Acid Inhibits Arterial Thrombus Formation, Tissue Factor Expression, and Platelet Activation (2011) (59)
Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. (2013) (59)
The endothelium in hypertension: bystander, target or mediator? (1994) (59)
The codex of science: honesty, precision, and truth--and its violations. (2013) (59)
Peripheral Blood Monocyte Sirt1 Expression Is Reduced in Patients with Coronary Artery Disease (2013) (59)
Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic β1-selective receptor blockade (2002) (59)
ECG-gated multi-detector row CT for assessment of mitral valve disease: initial experience (2002) (59)
Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare-Metal Stents in Acute Myocardial Infarction: Two-Year Clinical Results of the COMFORTABLE AMI Trial (2014) (59)
Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. (1995) (59)
Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. (1992) (58)
Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. (1992) (58)
Characteristics and long-term outcome of echocardiographic super-responders to cardiac resynchronisation therapy: ‘real world’ experience from a single tertiary care centre (2011) (58)
Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function. (2010) (58)
The endothelium in coronary artery disease. (1997) (58)
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents. (2016) (57)
Interaction Between Endothelium‐Derived Nitric Oxide and SIN‐1 in Human and Porcine Blood Vessels (1989) (57)
Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis (2017) (57)
Turbulent Kinetic Energy Assessed by Multipoint 4-Dimensional Flow Magnetic Resonance Imaging Provides Additional Information Relative to Echocardiography for the Determination of Aortic Stenosis Severity (2017) (56)
The endothelium in acute coronary syndromes. (1998) (56)
The perils of surrogate endpoints. (2015) (56)
Decreased umbilical artery compliance and igf-I plasma levels in infants with intrauterine growth restriction - implications for fetal programming of hypertension. (2009) (56)
Twitter promotion predicts citation rates of cardiovascular articles: a preliminary analysis from the ESC Journals Randomized Study. (2020) (56)
Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans. (2000) (55)
Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics (2019) (55)
Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial (2011) (55)
Effect of aging and hypertension on contractility of resistance arteries: modulation by endothelial factors. (1995) (55)
Coffee Blunts Mental Stress–Induced Blood Pressure Increase in Habitual but Not in Nonhabitual Coffee Drinkers (2005) (55)
Associated vascular lesions in patients with spontaneous coronary artery dissection. (2012) (55)
The role of p66Shc deletion in age-associated arterial dysfunction and disease states. (2008) (55)
Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation. (1999) (54)
Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. (1993) (54)
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments. (2004) (54)
Local anesthetic drugs reduce endothelium-dependent relaxations of porcine ciliary arteries. (1993) (54)
Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy. (2014) (54)
Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy (2019) (54)
Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome. (2019) (54)
Vasopeptidase Inhibition Exhibits Endothelial Protection in Salt-Induced Hypertension (2001) (54)
Accuracy of a new wrist cuff oscillometric blood pressure device: comparisons with intraarterial and mercury manometer measurements. (1998) (53)
p66Shc protein, oxidative stress, and cardiovascular complications of diabetes: the missing link (2009) (53)
Release of nitric oxide from human vascular smooth muscle cells. (1991) (53)
Predictors of long-term survival after valve replacement for chronic aortic regurgitation; is M-mode echocardiography sufficient? (2001) (53)
Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC). (2011) (53)
Cardiovascular Aging Is Associated With Vitamin E Increase (2002) (53)
Congenital coronary anomalies detected by coronary computed tomography compared to invasive coronary angiography (2014) (53)
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry (2019) (53)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies (2020) (52)
Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia. (2014) (52)
Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor (2019) (52)
Deletion of Sirt3 does not affect atherosclerosis but accelerates weight gain and impairs rapid metabolic adaptation in LDL receptor knockout mice: implications for cardiovascular risk factor development (2013) (52)
ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan. (1995) (51)
Endothelial dysfunction: the role and impact of the renin-angiotensin system (2000) (51)
Endothelin. Key to coronary vasospasm? (1991) (51)
Expression of the aging gene p66Shc is increased in peripheral blood monocytes of patients with acute coronary syndrome but not with stable coronary artery disease. (2012) (51)
Selective COX-2 Inhibitors and Renal Injury in Salt-Sensitive Hypertension (2005) (51)
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. (2016) (51)
Inhibition of Protein Kinase C&bgr; Prevents Foam Cell Formation by Reducing Scavenger Receptor A Expression in Human Macrophages (2008) (51)
Characterization of contractile endothelin and angiotensin receptors in human resistance arteries: evidence for two endothelin and one angiotensin receptor. (1994) (50)
Early and Late Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation: Comparison of the Novel EuroScore II with Established Risk Scores (2013) (50)
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury. (2018) (50)
Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia. (2007) (50)
High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease. (2010) (50)
[European National Society cardiovascular journals. Background, rationale and mission statement of the "Editors' Club"]. (2008) (50)
Glycogen Synthase Kinase-3 Mediates Endothelial Cell Activation by Tumor Necrosis Factor-α (2005) (50)
Endothelium Dysfunction in the Coronary Circulation (1994) (50)
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. (2016) (50)
Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis (2009) (49)
The circadian clock in cardiovascular regulation and disease: Lessons from the Nobel Prize in Physiology or Medicine 2017 (2018) (49)
Endothelin 1 Type A Receptor Antagonism Prevents Vascular Dysfunction and Hypertension Induced by 11&bgr;-Hydroxysteroid Dehydrogenase Inhibition: Role of Nitric Oxide (2001) (49)
Different Effects of Endothelin‐1 on cAMP‐and cGMP‐Mediated Vascular Relaxation in Human Arteries and Veins: Comparison with Norepinephrine (1989) (49)
Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo. (2016) (49)
Effects of calcium channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries. (1995) (49)
Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. (1991) (49)
The management of hyperuricemia and gout in patients with heart failure (2002) (49)
Aggravation of Focal Cerebral Ischemia by Tissue Plasminogen Activator Is Reversed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor but Does Not Depend on Endothelial NO Synthase (2005) (49)
Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease (2012) (49)
Academic detailing improves identification and reporting of adverse drug events (1999) (48)
Endothelin-1-induced release of thromboxane A2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts. (1996) (48)
Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes (2014) (48)
Mechanisms linking preterm birth to onset of cardiovascular disease later in adulthood (2019) (47)
Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. (1999) (47)
Low-dose heparin for routine coronary angioplasty and stenting. (1996) (47)
Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries. (2000) (47)
Cardiovascular effects of coffee: is it a risk factor? (2005) (46)
Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood-brain barrier integrity: a translational study. (2020) (46)
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia. (2009) (46)
The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. (2005) (46)
Adaptor Protein p66Shc Mediates Hypertension-Associated, Cyclic Stretch–Dependent, Endothelial Damage (2014) (45)
Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman (2017) (45)
Assessment and pathophysiology of microvascular disease: recent progress and clinical implications (2020) (45)
Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. (2009) (45)
Electrophysiological findings in patients with isolated left ventricular non-compaction. (2009) (45)
Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes. (2011) (45)
Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide. (1998) (44)
Pin1 inhibitor Juglone prevents diabetic vascular dysfunction. (2016) (44)
A rationale for treatment of endothelial dysfunction in hypertension. (1999) (43)
Molecular pathways of aging and hypertension (2009) (43)
Endothelial dysfunction in aorta of the spontaneously hypertensive, stroke-prone rat: effects of therapy with verapamil and trandolapril alone and in combination. (1994) (43)
PQ interval in patients with Fabry disease. (2010) (43)
Moving from impact to influence: measurement and the changing role of medical journals. (2012) (43)
Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone. (1993) (43)
Effect of atazanavir versus other protease inhibitor-containing antiretroviral therapy on endothelial function in HIV-infected persons: randomised controlled trial (2008) (43)
Internal-mammary coronary artery grafts: is their superiority also due to a basically intact endothelium? (1989) (43)
Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke (2018) (43)
Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. (2009) (43)
Drug-eluting stents—what should be improved? (2008) (43)
Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice (2002) (43)
Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes. (2015) (43)
Innate Signaling Promotes Formation of Regulatory Nitric Oxide–Producing Dendritic Cells Limiting T-Cell Expansion in Experimental Autoimmune Myocarditis (2013) (43)
Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. (2009) (42)
Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition (2001) (42)
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance (2017) (42)
Cardiovascular determinants of life span (2009) (42)
Cardiac Magnetic Resonance Imaging in Myocarditis Reveals Persistent Disease Activity Despite Normalization of Cardiac Enzymes and Inflammatory Parameters at 3-Month Follow-Up (2017) (42)
Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66Shc. (2018) (42)
Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study. (2019) (42)
Is the panic about beta-blockers in perioperative care justified? (2014) (41)
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland (2015) (41)
Cyclophilin A differentially activates monocytes and endothelial cells: role of purity, activity, and endotoxin contamination in commercial preparations. (2008) (41)
Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease (2017) (41)
25 years of coronary angioplasty: almost a fairy tale (2003) (41)
Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes (2017) (41)
Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease. (2012) (41)
Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARγ signature. (2019) (41)
Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans. (1997) (40)
Coexistence and outcome of coronary artery disease in Takotsubo syndrome. (2020) (40)
Effect of aging and hypertension on endothelial function of rat coronary arteries. (1991) (40)
Takotsubo Recurrence: Morphological Types and Triggers and Identification of Risk Factors. (2019) (40)
Maintenance of vascular integrity: role of nitric oxide and other bradykinin mediators. (1995) (39)
Endothelium and high blood pressure. (1997) (39)
Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding? (2015) (39)
Tissue Endothelin-Converting Enzyme Activity Correlates With Cardiovascular Risk Factors in Coronary Artery Disease (2000) (39)
Comparative Pharmacological Properties among Calcium Channel Blockers: T-Channel versus L-Channel Blockade (1998) (39)
Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. (2013) (39)
Decreased phosphatidylcholine plasmalogens--A putative novel lipid signature in patients with stable coronary artery disease and acute myocardial infarction. (2016) (39)
Good publishing practice. (2012) (39)
Exercise: friend or foe? (2013) (38)
Inflammation and cardiovascular diseases: lessons from seminal clinical trials. (2020) (38)
Feasibility and safety of outpatient radiofrequency catheter ablation procedures for atrial fibrillation (2010) (38)
Thrombus formation in the left ventricle after large myocardial infarction – assessment with cardiac magnetic resonance imaging. (2015) (38)
Differential Effects of the Calcium Antagonist Mibefradil in Epicardial and Intramyocardial Coronary Arteries (1995) (38)
Different effects of angiotensin-converting enzyme inhibition in human arteries and veins. (1993) (38)
Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity (2019) (38)
Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators. (2000) (38)
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases. (2020) (38)
Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center (2012) (38)
Do we need endothelin antagonists? (1993) (37)
Caffeine Impairs Myocardial Blood Flow Response to Physical Exercise in Patients with Coronary Artery Disease as well as in Age-Matched Controls (2009) (37)
Calcium gluconate in severe verapamil intoxication. (1994) (37)
Reconstituted HDL in acute coronary syndromes. (2012) (37)
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design. (2014) (37)
Circulating FABP4 Is a Prognostic Biomarker in Patients With Acute Coronary Syndrome but Not in Asymptomatic Individuals (2015) (37)
Role of Endogenous Fas (CD95/Apo-1) Ligand in Balloon-Induced Apoptosis, Inflammation, and Neointima Formation (2006) (37)
Endothelin receptor subtypes in small arteries. Studies with FR139317 and bosentan. (1995) (37)
Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin. (1995) (36)
Endothelin and endothelin antagonists: Potential role in cardiovascular and renal disease (1996) (36)
Relaxation by bradykinin in porcine ciliary artery. Role of nitric oxide and K(+)-channels. (1997) (36)
Similar endothelium-dependent relaxation, but enhanced contractility, of the right gastroepiploic artery as compared with the internal mammary artery. (1992) (36)
Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation (2013) (36)
Eisenhower's billion-dollar heart attack--50 years later. (2005) (36)
17β-Estradiol and Smooth Muscle Cell Proliferation in Aortic Cells of Male and Female Rats (1996) (36)
Appropriateness criteria for cardiovascular imaging use in clinical practice: a position statement of the ESC/EACVI taskforce. (2014) (36)
Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry. (2014) (36)
Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension. (2001) (36)
[2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment andmanagement]. (2014) (36)
Endothelial control of vascular tone and growth. (1990) (36)
Loss of Sirt3 accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity (2018) (35)
Is it all in the genes...? Nitric oxide synthase and coronary vasospasm. (1999) (35)
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial (2018) (35)
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways. (2015) (35)
Human Antibody Against C Domain of Tenascin-C Visualizes Murine Atherosclerotic Plaques Ex Vivo (2007) (35)
Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment–Elevation Myocardial Infarction: Role of Differential MicroRNA-378 Expression (2017) (35)
Renal venous renin determinations in renovascular hypertension. Diagnostic and prognostic value in unilateral renal artery stenosis treated by surgery or percutaneous transluminal angioplasty. (1986) (35)
Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios (2014) (34)
Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week. (2022) (34)
Heart failure: the cardiovascular epidemic of the 21st century. (2015) (34)
ApoE−/− PGC-1α−/− Mice Display Reduced IL-18 Levels and Do Not Develop Enhanced Atherosclerosis (2010) (34)
Vascular biology of coronary bypass grafts (1991) (34)
Systemic Inhibition of Nitric Oxide Synthase Unmasks Neural Constraint of Maximal Myocardial Blood Flow in Humans (2004) (34)
Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study. (2012) (34)
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design. (2012) (33)
Effects of blood pressure and glucose on endothelial function (2001) (33)
The European Heart Journal goes global: the road ahead of the editorial team 2009-2011. (2008) (33)
Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging. (2018) (33)
Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation (2011) (33)
Pulsatile Stretch Induces Release of Angiotensin II and Oxidative Stress in Human Endothelial Cells: Effects of ACE Inhibition and AT1 Receptor Antagonism (2008) (33)
Increased Balloon-Induced Inflammation, Proliferation, and Neointima Formation in Apolipoprotein E (ApoE) Knockout Mice (2006) (33)
DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? (2010) (33)
Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials (2018) (33)
Age-Related Changes of Vitamin A Status (2004) (32)
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis (2018) (32)
From Eisenhower’s heart attack to modern management: a true success story! (2017) (32)
Cyclooxygenase-2 Inhibition and Coagulation (2006) (32)
Endothelium-dependent control of vascular tone: effects of age, hypertension and lipids. (1991) (32)
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen. (2018) (32)
Inverse regulation of endothelin-1 and nitric oxide metabolites in tissue with aging: implications for the age-dependent increase of cardiorenal disease. (2000) (31)
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry (2020) (31)
Endothelin in atherosclerosis: importance of risk factors and therapeutic implications. (2000) (31)
Epigenetic Control of Mitochondrial Function in the Vasculature (2020) (31)
Effect of endothelin antagonists on the responses to prostanoid endothelium‐derived contracting factor (1996) (31)
Different Cell Cycle Regulation of Vascular Smooth Muscle in Genetic Hypertension (2003) (31)
Unilateral hydronephrosis and hypertension: cause or coincidence? (1987) (31)
Epigenetics and cardiovascular regenerative medicine in the elderly. (2018) (31)
Age-Related Variations in Takotsubo Syndrome. (2020) (31)
17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. (1996) (31)
Protection of endothelial function. (2005) (31)
Angiotensin converting enzyme inhibitors and vascular protection in hypertension. (1999) (31)
CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease--the ENCORE Trials. (2009) (31)
Anti-Aging Medicine: Molecular Basis for Endothelial Cell-Targeted Strategies – A Mini-Review (2010) (30)
Interaction of systolic blood pressure and resting heart rate with clinical outcomes in takotsubo syndrome: insights from the International Takotsubo Registry (2018) (30)
AP-1 (Activated Protein-1) Transcription Factor JunD Regulates Ischemia/Reperfusion Brain Damage via IL-1&bgr; (Interleukin-1&bgr;) (2019) (30)
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention? (2018) (30)
Prognostic value of long‐term blood pressure changes in patients with chronic heart failure (2017) (30)
Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme. (2012) (30)
Laminin receptor activation inhibits endothelial tissue factor expression. (2009) (30)
Pharmacology of the calcium antagonist mibefradil (1997) (30)
Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. (2021) (30)
Quality of Care after Acute Coronary Syndromes in a Prospective Cohort with Reasons for Non-Prescription of Recommended Medications (2014) (30)
Nebivolol inhibits human aortic smooth muscle cell growth: effects on cell cycle regulatory proteins. (2000) (30)
Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs. (1998) (30)
The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis. (2017) (30)
Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial. (2010) (30)
"One-Stop Shop": Safety of Combining Transcatheter Aortic Valve Replacement and Left Atrial Appendage Occlusion. (2016) (30)
Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia (2015) (30)
Reprogramming ageing and longevity genes restores paracrine angiogenic properties of early outgrowth cells. (2016) (29)
Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1. (1997) (29)
The cardioprotective effects of statins (2004) (29)
Vascular biology of coronary bypass grafts. (1991) (29)
Multivessel versus culprit vessel percutaneous coronary intervention in ST-elevation myocardial infarction: is more worse? (2013) (29)
Hybrid SPECT Perfusion Imaging and Coronary CT Angiography: Long-term Prognostic Value for Cardiovascular Outcomes. (2018) (29)
Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. (2018) (29)
Molecular and cellular biology of endothelin and its receptors--Part II. (1993) (29)
Differential modulation of the renal and myocardial endothelin system by angiotensin II in Vivo. Effects of chronic selective ETA receptor blockade. (1998) (29)
Mild endothelial dysfunction in Sirt3 knockout mice fed a high-cholesterol diet: protective role of a novel C/EBP-β-dependent feedback regulation of SOD2 (2016) (29)
Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling (2014) (29)
Endothelin, endothelin receptors, and endothelin antagonists. (1994) (28)
Increased Expression of miR-483-3p Impairs the Vascular Response to Injury in Type 2 Diabetes (2018) (28)
Diabetes and the Heart (2004) (28)
Renal Venous Renin Determinations in Renovascular Hypertension (1986) (28)
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes. (2015) (28)
Coronary artery stent geometry and in-stent contrast attenuation with 64-slice computed tomography (2007) (28)
Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels. (2000) (27)
Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries (2009) (27)
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways (2017) (27)
Felodipine inhibits free-radical production by cytokines and glucose in human smooth muscle cells. (1998) (27)
Influence of lipoproteins on endothelial function. (1994) (27)
Differential effect of cyclic GMP on the release of endothelin-1 from cultured endothelial cells and intact porcine aorta. (1991) (27)
Enhanced age-dependent cerebrovascular dysfunction is mediated by adaptor protein p66Shc. (2014) (27)
Coronary computed tomography angiography indicates complexity of percutaneous coronary interventions. (2012) (27)
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease. (2020) (27)
Arrhythmic manifestations in patients with congenital left ventricular aneurysms and diverticula. (2011) (27)
Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry. (2019) (27)
Impact of postdilatation on performance of bioresorbable vascular scaffolds in patients with acute coronary syndrome compared with everolimus-eluting stents: A propensity score-matched analysis from a multicenter "real-world" registry. (2016) (27)
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes (2017) (27)
Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-alpha. (2005) (27)
GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis. (2013) (27)
Acute coronary syndromes in octogenarians referred for invasive evaluation: treatment profile and outcomes (2014) (27)
Ischemic stroke across sexes: What is the status quo? (2018) (27)
High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation (2014) (26)
Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders (2001) (26)
Basic cellular mechanisms of coronary bypass graft disease. (1993) (26)
Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. (2002) (26)
Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery (2008) (26)
Expression and Activity Patterns of Nitric Oxide Synthases and Antioxidant Enzymes Reveal a Substantial Heterogeneity Between Cardiac and Vascular Aging in the Rat (2005) (26)
Aging Induces Endothelial Dysfunction While Sparing Arterial Thrombosis (2010) (26)
Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls. (2016) (26)
Deletion of L-Selectin Increases Atherosclerosis Development in ApoE−/− Mice (2011) (26)
Combination of ACE inhibitors and calcium antagonists: a logical approach. (1998) (26)
Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis (2019) (26)
Inflammation in Metabolic Cardiomyopathy (2021) (26)
CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trials. (2012) (26)
Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function. (2000) (26)
Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications. (2013) (25)
Vascular protective effects of ACE inhibitors and calcium antagonists: Theoretical basis for a combination therapy in hypertension and other cardiovasular diseases (1995) (25)
Different wall motion patterns of three consecutive episodes of takotsubo cardiomyopathy in the same patient. (2012) (25)
HDL and inflammation in atherosclerosis. (2004) (25)
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism. (2019) (25)
Renal venous renin activity in various forms of curable renal hypertension. (1981) (25)
Amiodarone Inhibits Arterial Thrombus Formation and Tissue Factor Translation (2008) (25)
Therapeutic targets to raise HDL in patients at risk or with coronary artery disease. (2012) (25)
Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors (2009) (25)
Cocaine unbalances endothelial tissue factor and tissue factor pathway inhibitor expression. (2006) (25)
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes (2017) (25)
The bumpy road to evidence: why many research findings are lost in translation. (2013) (25)
Rehabilitation after TAVI compared to surgical aortic valve replacement. (2014) (24)
Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes (2013) (24)
Rheumatoid arthritis and coronary atherosclerosis: two cousins engaging in a dangerous liaison (2015) (24)
Dual Role of Endothelial Nitric Oxide Synthase in Oxidized LDL-Induced, p66Shc-Mediated Oxidative Stress in Cultured Human Endothelial Cells (2014) (24)
Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression (2017) (24)
Predicting the development of atherosclerosis. (2009) (24)
Different Migration of Vascular Smooth Muscle Cells from Human Coronary Artery Bypass Vessels (2007) (24)
Coronary Artery Graft Disease (1994) (24)
Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. (2017) (24)
Registry for the Evaluation of the PROgnostic value of a novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT). (2013) (24)
Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy (2015) (23)
Isolated acute iatrogenic aortic dissection during percutaneous coronary intervention without involvement of the coronary arteries. (2008) (23)
Assessing the association between mental disorders, cardiovascular risk factors, and cardiovascular disease: the CoLaus/PsyCoLaus study (2011) (23)
Different Vascular Smooth Muscle Cell Apoptosis in the Human Internal Mammary Artery and the Saphenous Vein (2006) (23)
Patterns of Alcohol Consumption and Acute Myocardial Infarction: A Case-Crossover Analysis (2009) (23)
The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trial. (2014) (23)
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction. (2019) (23)
Current Strategies and Perspectives for Correcting Endothelial Dysfunction in Atherosclerosis (2001) (23)
Omega‐3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism (2017) (23)
The Potential for Inappropriate Ventricular Tachycardia Confirmation Using the Intracardiac Electrogram (EGM) Width Criterion (1999) (23)
The Classification of Calcium Antagonists and their Selection in the Treatment of Hypertension (1998) (23)
Restraint stress enhances arterial thrombosis in vivo – role of the sympathetic nervous system (2014) (23)
Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis. (2013) (23)
Interactions between endothelin and endothelium-derived relaxing factor (1992) (23)
A Novel Electrocardiographic Index for the Diagnosis of Diastolic Dysfunction (2013) (22)
Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension. (2001) (22)
Platelet-vessel wall interaction: role of nitric oxide, prostaglandins and endothelins. (1993) (22)
Gender disparities in acute coronary syndrome: a closing gap in the short-term outcome (2015) (22)
Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy. (2016) (22)
Alterations in coronary artery vascular reactivity of hypertensive Ren-2 transgenic rats. (1994) (22)
Ageing, inflammation, and oxidative stress: final common pathways of cardiovascular disease. (2015) (22)
Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE‐CARDIOGROUP IV and USZ registry (2017) (22)
Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats. (1997) (22)
Lack of nuclear apoptosis in cardiomyocytes and increased endothelin-1 levels in a rat heart model of myocardial stunning (2000) (21)
Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. (2010) (21)
Vascular Effects of Newer Cardiovascular Drugs: Focus on Nebivolol and ACE‐Inhibitors (2001) (21)
Chronic Blockade of Nitric Oxide-Synthase and Endothelin Receptors During Pregnancy in the Rat: Effect on Pregnancy Outcome (1998) (21)
Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension. (2005) (21)
Hyperglycemia Induces Myocardial Dysfunction via Epigenetic Regulation of JunD (2020) (21)
N‐terminal pro‐B‐type natriuretic peptide‐ratio predicts mortality after transcatheter aortic valve replacement (2015) (21)
Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before–after study with parallel group comparisons (2016) (21)
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes (2019) (21)
Treatment of acute pulmonary hypertension with inhaled nitric oxide. (1994) (21)
A PET/CT-follow-up imaging study to differentiate takotsubo cardiomyopathy from acute myocardial infarction (2013) (21)
Associations between alcohol consumption and selected cytokines in a Swiss population-based sample (CoLaus study). (2012) (21)
Impact of aspirin on takotsubo syndrome: a propensity score‐based analysis of the InterTAK Registry (2019) (21)
Midazolam premedication improves tolerance of transesophageal echocardiography. (1998) (21)
Endothelium-derived vasoactive factors and regulation of vascular tone in human blood vessels (2007) (21)
Ablation of atrial fibrillation after the retirement age: considerations on safety and outcome (2010) (20)
Coronary Artery Graft Disease: Mechanisms and Prevention (1994) (20)
Adherence to medication. (1990) (20)
Aging, Serum Estradiol Levels, and Pregnancy Differentially Affect Vascular Reactivity of the Rat Uterine Artery (2000) (20)
Mechanisms of Altered Endothelium-Dependent Responses in Hypertensive Blood Vessels (1988) (20)
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61 (2019) (20)
Gender-Related Differences in Patients Presenting with Suspected Acute Coronary Syndromes: Clinical Presentation, Biomarkers and Diagnosis (2015) (20)
Calcium antagonists and sympathetic nerve activation: are there differences between classes? (1998) (20)
Catheter-based renal denervation: the next chapter begins. (2018) (20)
Nitrate induced coronary vasodilatation: differential effects of sublingual application by capsule or spray (1998) (20)
Takotsubo cardiomyopathy associated with opiate withdrawal. (2014) (20)
Cardiac Glycosides Regulate Endothelial Tissue Factor Expression in Culture (2007) (20)
The Endothelium as a Regulator of Vascular Tone and Growth (1995) (20)
Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis. (2021) (20)
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy. (2021) (20)
Vascular protection: current possibilities and future perspectives. (2001) (19)
Endothelin and endothelin antagonists: pharmacology and clinical implications. (1995) (19)
ORBITA revisited: what it really means and what it does not? (2018) (19)
Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1. (2020) (19)
Management of refractory angina: an update. (2020) (19)
[HIV infection, antiretroviral therapy, and endothelium]. (2005) (19)
Long-term follow-up of patients with isolated left ventricular noncompaction: role of electrocardiography in predicting poor outcome. (2011) (19)
Heart failure subgroups: HFrEF, HFmrEF, and HFpEF with or without mitral regurgitation. (2018) (19)
Endothelin regulates angiotensin-converting enzyme in the mouse kidney. (2000) (19)
Novel doppler assessment of intracoronary volumetric flow reserve: validation against PET in patients with or without flow-dependent vasodilation. (2005) (19)
Combined Two-Dimensional Ultrasound Doppler Technique (1986) (19)
Cardiovascular magnetic resonance for the assessment of coronary artery disease. (2015) (19)
Clinical Predictors and Prognostic Impact of Recovery of Wall Motion Abnormalities in Takotsubo Syndrome: Results From the International Takotsubo Registry (2019) (19)
Substance P in human hand veins in vivo: Tolerance, efficacy, potency, and mechanism of venodilator action (1996) (19)
TAVI in a low left main coronary artery ostium and wide aortic sinus of Valsava. (2014) (18)
Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice—an underestimated complication? (2017) (18)
Long-Term Follow-up of Patients With Isolated Left Ventricular Noncompaction (2011) (18)
Endothelium-dependent vasomotion in aging, hypertension, and heart failure (1993) (18)
2D-spatially-selective real-time magnetic resonance imaging for the assessment of microvascular function and its relation to the cardiovascular risk profile. (2006) (18)
Oxidative stress-associated vascular aging is independent of the protein kinase C/NAD(P)H oxidase pathway. (2004) (18)
Effect of dipyridamole on vascular responses of porcine ciliary arteries. (1996) (18)
Systematic use of cardiac magnetic resonance imaging in MINOCA led to a five-fold increase in the detection rate of myocarditis: a retrospective study. (2019) (18)
Characterization of Pulmonary Vein Dimensions Using High-Definition 64-Slice Computed Tomography prior to Radiofrequency Catheter Ablation for Atrial Fibrillation (2014) (18)
Sports and exercise. (2014) (18)
Acetylsalicylic Acid, at High Concentrations, Inhibits Vascular Smooth Muscle Cell Proliferation (1993) (18)
The Endothelium in Cardiovascular Disease (1995) (18)
Human connective tissue growth factor expressed in Escherichia coli is a non-mitogenic inhibitor of apoptosis. (2003) (17)
Prognostic value of PCSK 9 levels in patients with acute coronary syndromes (2016) (17)
The role of European national journals in education (2009) (17)
PDGF-CC induces tissue factor expression: role of PDGF receptor α/β (2010) (17)
Influence of endothelial surface on flow velocity in vitro. (1993) (17)
Efficacy and Safety of Various Combination Therapies Based on a Calcium Antagonist in Essential Hypertension: Results of a Placebo‐Controlled Randomized Trial (1993) (17)
Novel Insights Into the Critical Role of Bradykinin and the Kinin B2 Receptor for Vascular Recruitment of Circulating Endothelial Repair–Promoting Mononuclear Cell Subsets: Alterations in Patients With Coronary Disease (2013) (17)
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome (2018) (17)
Differential effects of endothelin-1 on normal and postischemic reperfused myocardium. (1993) (17)
Endothelin in cardiovascular control: The role of endothelin antagonists (1999) (17)
Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke. (2020) (17)
Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging. (2004) (17)
Inpatient versus outpatient onsets of acute myocardial infarction. (2015) (17)
Propofol-induced relaxation of rat mesenteric arteries: evidence for a cyclic GMP-mediated mechanism. (1998) (17)
Double Transseptal Puncture for Catheter Ablation of Atrial Fibrillation: Safety of the Technique and Its Use in the Outpatient Setting (2010) (16)
Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England (2020) (16)
Postoperative hemodynamics depend on cardiopulmonary bypass temperature: the potential role of endothelin-1. (1997) (16)
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase. (2017) (16)
Ageing and longevity genes in cardiovascular diseases. (2020) (16)
The spectrum of renovascular hypertension. (1985) (16)
Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves. (2015) (16)
Lumpers and splitters: the Bumby road to precision medicine. (2019) (16)
Delayed femoral vein thrombosis after ultrasound-guided thrombin injection of a postcatheterization pseudoaneurysm. (2003) (16)
First case of atypical takotsubo cardiomyopathy in a bilateral lung-transplanted patient due to acute respiratory failure (2015) (16)
Inflammation: the new cardiovascular risk factor. (2018) (16)
The ESC Textbook of Cardiovascular Medicine (2nd edition) (2009) (16)
Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction. (2011) (16)
Endothelial function in coronary artery disease. (1997) (16)
Age-associated cellular relocation of Sod 1 as a self-defense is a futile mechanism to prevent vascular aging. (2006) (16)
Impact of Final Kissing Balloon and of Imaging on Patients Treated on Unprotected Left Main Coronary Artery With Thin-Strut Stents (From the RAIN-CARDIOGROUP VII Study). (2019) (16)
β-Adrenergic agonist-induced nitrite production in isolated pig ciliary processes (1998) (16)
Insufficient Medication Documentation at Hospital Admission of Cardiac Patients: A Challenge for Medication Reconciliation (2009) (16)
Happy birthday European Heart Journal: in 30 years, from Cinderella to centre stage. (2010) (16)
Spontaneous calcium-independent nitric oxide synthase activity in porcine ciliary processes. (1996) (16)
Low statin use in adults hospitalized with acute coronary syndrome. (2015) (16)
Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy. (2016) (16)
Factor-Glycogen Synthase Kinase-3 Mediates Endothelial Cell Activation by Tumor Necrosis (2005) (16)
Different effects of activated platelets in the right gastroepiploic and internal mammary arteries. Implications for coronary artery grafting. (1992) (16)
Endothelin antagonists and heart failure (2002) (15)
Altered Intra- and Extraluminal Effects of 5‐Hydroxytryptamine in Hypertensive Mesenteric Resistance Arteries: Contribution of the Endothelium and Smooth Muscle (1991) (15)
Anatomical and procedural determinants of catheter-based renal denervation. (2016) (15)
Are there interactions between S2-serotonergic and alpha 1-adrenergic receptors in isolated canine arteries? (1988) (15)
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury (2018) (15)
The Beauty and the Beast: Aspects of the Autonomic Nervous System. (2000) (15)
Heart failure and comorbidities: renal failure, diabetes, atrial fibrillation, and inflammation. (2015) (15)
A novel flow cytometry‐based assay to study leukocyte–endothelial cell interactions in vitro (2011) (15)
Heart non-specific effector CD4+ T cells protect from postinflammatory fibrosis and cardiac dysfunction in experimental autoimmune myocarditis (2019) (15)
Absence of histamine-induced nitric oxide release in the human radial artery: implications for vasospasm of coronary artery bypass vessels. (2006) (15)
Arrhythmias and sudden death. (2015) (15)
Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? (1997) (15)
Different Potency of Endothelium‐Derived Relaxing Factors Against Thromboxane, Endothelin, and Potassium Chloride in Intramyocardial Porcine Coronary Arteries (1991) (15)
Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in Patients With Heart Failure With and Without Anemia. (2016) (15)
Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists. (1998) (15)
Multi-centre study of whole-heart dynamic 3D cardiac magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: gender based analysis of diagnostic performance (2017) (15)
Pre-existing treatment with aspirin or statins influences clinical presentation, infarct size and inflammation in patients with de novo acute coronary syndromes. (2019) (15)
Impact of Three‐Dimensional Imaging and Pressure Recovery on Echocardiographic Evaluation of Severe Aortic Stenosis: A Pilot Study (2014) (15)
Inflammation during acute coronary syndromes - Risk of cardiovascular events and bleeding. (2019) (15)
Autonomic Nervous System‐Controlled Cardiac Pacing: A Comparison Between Intracardiac Impedance Signal and Muscle Sympathetic Nerve Activity (2000) (15)
Folic Acid Improves Baroreceptor Sensitivity in Hypertension (2005) (15)
Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension. (2018) (15)
The relationship between the endothelium and the vessel wall (2002) (15)
Endothelial Nitric Oxide Synthase Gene Transfer Inhibits Human Smooth Muscle Cell Migration via Inhibition of Rho A (2008) (15)
Prevention: some important steps forward, but many unmet needs in a world with cardiovascular disease as the leading cause of death. (2016) (14)
Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients. (2015) (14)
Prognostic value of pulse pressure after an acute coronary syndrome. (2018) (14)
Endothelin in renal disease: role of endothelin antagonists. (1995) (14)
Amlodipine and benazeprilat differently affect the responses to endothelin-1 and bradykinin in porcine ciliary arteries: effects of a low and high dose combination. (1997) (14)
Serotonin and the endothelium. (1990) (14)
In search of the right word: a statement of the HEART Group on scientific language. (2013) (14)
The best of the European Heart Journal: look back with pride. (2012) (14)
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study. (2010) (14)
Corrected formula for the calculation of the electrical heart axis. (1999) (14)
Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome. (2013) (14)
Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein. (2004) (14)
Activity of the L‐Arginine/Nitric Oxide Pathway and Endothelin‐1 in Experimental Heart Failure (1994) (14)
Dietary α-linolenic acid increases the platelet count in ApoE-/- mice by reducing clearance. (2013) (14)
Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up (2019) (14)
Prediction of short‐ and long‐term mortality in takotsubo syndrome: the InterTAK Prognostic Score (2019) (14)
Unilateral parenchymatous kidney disease and hypertension: results of nephrectomy and medical treatment. (1985) (14)
"Endothelial progenitor cells" as a therapeutic strategy in cardiovascular disease. (2012) (13)
Antibody Phage Display Assisted Identification of Junction Plakoglobin as a Potential Biomarker for Atherosclerosis (2012) (13)
Health utility indexes in patients with acute coronary syndromes (2016) (13)
Endothelial Dysfunction, Hypertension and Atherosclerosis (2002) (13)
Drug-eluting stents vs. bare metal stents in patients with cardiogenic shock: a comparison by propensity score analysis (2015) (13)
The sooner, the better: anti-inflammation in acute myocardial infarction. (2020) (13)
Fractional Flow Reserve Evaluation in Patients Considered for Transfemoral Transcatheter Aortic Valve Implantation: A Case Series (2012) (13)
HIV-Infektion, antiretrovirale Therapie und Endothel (2005) (13)
The year in cardiology: acute coronary syndromes. (2020) (13)
Diversity is richness: why data reporting according to sex, age, and ethnicity matters. (2020) (13)
Molecular and cellular mechanisms of atherosclerosis. (1995) (13)
Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle. (1993) (13)
Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice (2014) (13)
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations. (2015) (13)
Myocardial infarction: mechanisms, diagnosis, and complications. (2015) (13)
Altered Activation of Endothelial Anti- and Pro-Apoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease: Role of HDL-Proteome Remodeling (2013) (12)
Surgery, transluminal dilatation and medical therapy in the management of renovascular hypertension. (1986) (12)
Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery. (1998) (12)
Flow: the signal of life. (2004) (12)
Cardiac pre-competiton screening in Swiss athletes. Current situation in competitive athletes and short-time assessment of an exemplary local screening program. (2012) (12)
Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension. (2001) (12)
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). (2019) (12)
From ‘essential’ hypertension to intensive blood pressure lowering: the pros and cons of lower target values (2017) (12)
Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement (2015) (12)
High Dose Lisinopril in Heart Failure: Economic Considerations (2002) (12)
Stem cells in cardiovascular regeneration: from preservation of endogenous repair to future cardiovascular therapies. (2011) (12)
Medical Misinformation. (2019) (12)
Spontanous periodic breathing is associated with sympathetic hyperreactivity and baroreceptor dysfunction in hypertension (2010) (12)
Anxiolytic therapy with alprazolam increases muscle sympathetic activity in patients with panic disorders (2007) (12)
[Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study]. (2001) (12)
Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes undergoing left main percutaneous coronary intervention. (2011) (12)
Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells. (2006) (12)
Deletion of fibroblast activation protein provides atheroprotection. (2020) (12)
Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery (2007) (12)
Endothelial dysfunction in the aorta of transgenic rats harboring the mouse Ren-2 gene. (1999) (12)
Renovascular and Renal Parenchymatous Hypertension (1992) (12)
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines. (2020) (12)
Vasopeptidase inhibitors--concepts and evidence. (2001) (12)
Clinical Criteria Replenish High-Sensitive Troponin and Inflammatory Markers in the Stratification of Patients with Suspected Acute Coronary Syndrome (2014) (12)
Angiotensin-converting enzyme inhibition and endothelial dysfunction: focus on ramipril (2003) (12)
Impact of gender on outcomes after transcatheter aortic valve implantation (2018) (12)
Endothelial vasoconstrictor prostanoids, vascular reactivity, and acute renal failure. (1998) (11)
Altered Left Ventricular Contraction Pattern during Right Ventricular Pacing: Assessment Using Real‐Time Three‐Dimensional Echocardiography (2011) (11)
Unfavorable Donor Pretransplant APACHE II, SAPS II, and SOFA Scores Are Not Associated With Outcome: Implications for Heart Transplant Donor Selection. (2016) (11)
SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration (2017) (11)
Anti-inflammatory therapies for cardiovascular disease (2018) (11)
An exosomal-carried short periostin isoform induces cardiomyocyte proliferation (2021) (11)
Detection of a Novel Exon 4 Low-Density Lipoprotein Receptor Gene Deletion in a Swiss Family with Severe Familial Hypercholesterolemia (2003) (11)
Scientific integrity: what a journal can and cannot do. (2020) (11)
Comprehensive cardiac resynchronization therapy optimization in the real world. (2014) (11)
Connective tissue growth factor inhibits proliferation of human aortic smooth muscle cells (1998) (11)
Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry (2021) (11)
Calcium antagonists and ACE inhibitors : effect on endothelium and vascular smooth muscle. Discussion (1993) (11)
The role of European national journals in education. (2010) (11)
Clinical Presentation and Laboratory Findings in Men Versus Women with Myocarditis. (2020) (11)
NT‐proBNP Provides Incremental Prognostic Information in Cardiac Outpatients With and Without Echocardiographic Findings (2011) (11)
Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries (2020) (11)
Endothelin-induced vasoconstriction and calcium antagonists. (1992) (11)
The year in cardiology 2018: acute coronary syndromes. (2019) (11)
Effect of Ox-LDL on endothelium-dependent response in pig ciliary artery: prevention by an ET(A) antagonist. (1999) (11)
The Hygia trial: Discussions about surprising results. (2020) (11)
Impact of stroke volume assessment by integrating multi-detector computed tomography and Doppler data on the classification of aortic stenosis. (2017) (11)
Beyond Traditional Risk Factors: Homocysteine and Atherosclerosis (2001) (11)
Epidemiology of cardiovascular disease: the new ESC Atlas and beyond. (2018) (10)
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology (2021) (10)
Burden and impact of congenital syndromes and comorbidities among adults with congenital heart disease. (2017) (10)
Chronic Blockade of Nitric Oxide Synthase and Endothelin Receptors During Pregnancy in the Rat: Effect on Reactivity of the Uterine Artery In Vitro (1998) (10)
Cardiovascular disease and pregnancy (1999) (10)
Cardiovascular Regulation: Basic Considerations (2007) (10)
[Factors determining compliance in hypertensive patients]. (1982) (10)
Novel mechanisms of atherosclerosis and cardiovascular repair. (2016) (10)
The 2018 ESC-ESH guidelines for the management of arterial hypertension leave clinicians facing a dilemma in half of the patients. (2018) (10)
Problem cases in renovascular hypertension. (1983) (10)
Carnitine — from cellular mechanisms to potential clinical applications in heart disease (1997) (10)
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study (2020) (10)
New prospects for PCSK9 inhibition? (2018) (10)
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 (2019) (10)
Impact of growing cohorts of adults with con-genital heart disease on clinical workload: a 20-year experience at a tertiary care centre. (2017) (10)
Endothelium, lipoproteins and atherosclerotic vascular disease (1991) (10)
17 beta-Estradiol and smooth muscle cell proliferation in aortic cells of male and female rats. (1996) (10)
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium (2017) (10)
Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST‐Elevation Myocardial Infarction: Results From a Multi‐Center Randomized Trial (2017) (10)
Measuring the unmeasurable: assessing the quality of science and scientists. (2018) (9)
Circadian Carbamazepine Toxicity (1994) (9)
Age and the platelet serotonin vasoconstrictor axis in essential hypertension. (1988) (9)
Novel Blood Biomarkers for a Diagnostic Workup of Acute Aortic Dissection (2021) (9)
Reincarnated medicines: using out-dated drugs for novel indications. (2016) (9)
Myoglobin for Detection of High-Risk Patients with Acute Myocarditis (2020) (9)
Vascular biology of human coronary artery and bypass graft disease (1993) (9)
Histamine H 1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins (2010) (9)
Nitric oxide production by isolated human and porcine ciliary processes (2000) (9)
MMP-2 knockdown blunts age-dependent carotid stiffness by decreasing elastin degradation and augmenting eNOS activation. (2021) (9)
Glycoprotein Ib clustering in platelets can be inhibited by α-linolenic acid as revealed by cryo-electron tomography (2019) (9)
Prevention is better than cure: the new ESC Guidelines. (2016) (9)
Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis. (2020) (9)
What is a normal blood pressure? (2018) (9)
Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease (2012) (9)
SPRINT: the race for optimal blood pressure control. (2016) (9)
Cardiac quadruple-fusion imaging: a brief report on a novel integrated multimodality approach for in vivo visualization of transplanted stem cells. (2012) (9)
Relationship Between Peak Troponin Values and Long‐Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes (2017) (9)
Lifelong dietary omega-3 fatty acid suppresses thrombotic potential through gut microbiota alteration in aged mice (2021) (9)
Endothelin receptor antagonists in heart failure—a refutation of a bold conjecture? (2003) (9)
Misconceptions and Facts About Takotsubo Syndrome. (2019) (9)
Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs (2021) (9)
Incidence and prognosis of ventricular arrhythmias in patients with congenital left ventricular aneurysms or diverticula. (2015) (9)
Endothelium and Vascular Smooth Muscle Function of Coronary Bypass Grafts (1994) (9)
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus. (2014) (9)
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic system. (2020) (9)
Profibrotic potential of Prominin-1+ epithelial progenitor cells in pulmonary fibrosis (2011) (9)
Incidence of Adverse Events at 3 Months Versus at 12 Months After Dual Antiplatelet Therapy Cessation in Patients Treated With Thin Stents With Unprotected Left Main or Coronary Bifurcations. (2019) (9)
Virome Sequencing in Patients With Myocarditis (2020) (9)
Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine. (2002) (9)
[Subjective tolerance to transesophageal echocardiography]. (1994) (8)
The wealth of nations and the dissemination of cardiovascular research. (2013) (8)
[How do blood vessels age? Mechanisms and clinical implications]. (2004) (8)
Inflammation and features of the vulnerable plaque: from mechanisms and imaging to outcomes. (2020) (8)
Acute effects of 17 beta-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins. (2002) (8)
Atrial fibrillation beyond the arrhythmia: hypercoagulability, adipose tissue, and fibrotic remodelling. (2017) (8)
Platelet-derived growth factor-induced vasodilatation in mesenteric resistance arteries by nitric oxide: blunted response in spontaneous hypertension. (1999) (8)
Constitutively overexpressed erythropoietin reduces infarct size in a mouse model of permanent coronary artery ligation. (2007) (8)
Medical Misinformation: Vet the Message! (2019) (8)
The role of p 66 Shc deletion in age-associated arterial dysfunction and disease states (2008) (8)
Endothelium in the control of vascular tone and growth: role of local mediators and mechanical forces. (1994) (8)
Vascular Effects of Eplerenone in Coronary Artery Disease With Preserved Ejection Fraction: A Double‐Blind, Randomized, Placebo‐Controlled Trial (2016) (8)
Frontiers in lipid research. (2015) (8)
TNF‐α antagonism rescues the effect of ageing on stroke: Perspectives for targeting inflamm‐ageing (2021) (8)
Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients. (2019) (8)
Different interaction of platelets with arterial and venous coronary bypass grafts: Role of nitric oxide and antiplatelet drugs (1991) (8)
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes (2019) (8)
Vasopeptidase inhibition: Effective blood pressure control for vascular protection (2002) (8)
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing (2012) (8)
Corrigendum to: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia. (2017) (8)
Standing firm—the European Heart Journal, scientific controversies and the industry (2010) (8)
Back to square one. (2019) (8)
Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. (2018) (8)
Combined two-dimensional ultrasound Doppler technique. New possibilities for the screening of renovascular and parenchymatous hypertension? (1986) (8)
[Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals]. (2012) (8)
Apold1 deficiency associates with increased arterial thrombosis in vivo (2019) (8)
New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on Epigenetics (2020) (8)
Endothelium-dependent vascular responses: effect of hypertension and cyclosporin A. (1989) (8)
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohort (2017) (8)
Treatment with darusentan over 21 days improved cGMP generation in patients with chronic heart failure. (2002) (8)
Pulsatile stretch and platelet-derived growth factor (PDGF): Important mechanisms for coronary venous bypass graft disease (1994) (8)
Allograft vasculopathy vs. coronary artery disease: comparison by optical coherence tomography. (2013) (8)
Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts (2018) (8)
Endothelin-1 potentiates contractions to norepinephrine and serotonin in human mammary and coronary arteries (1990) (7)
Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiography (2018) (7)
Starting a carotid artery stenting program is safe (2008) (7)
Clinical evaluation of semiautomatic blood pressure devices for self-recording. (1985) (7)
Transcatheter aortic valve-in-valve implantation: clinical outcome as defined by VARC-2 and postprocedural valve dysfunction according to the primary mode of bioprosthesis failure. (2014) (7)
The endothelial L-arginine/nitric oxide pathway and the renal circulation (1991) (7)
Left-sided haemothorax after iatrogenic coronary perforation in a patient with prior bypass surgery. (2015) (7)
Assessment of cardiovascular risk: time to apply genetic risk factors? (2000) (7)
[Molecular and cellular mechanisms of arteriosclerosis and restenosis: possibilities of gene therapy]. (1996) (7)
[Patient compliance (author's transl)]. (1982) (7)
Changes in serum biomarker profiles after percutaneous mitral valve repair with the MitraClip system. (2016) (7)
Association of endothelin-1 with transient myocardial ischemia in patients with unstable angina pectoris. (2005) (7)
Calcium Antagonists as First‐Line Therapy in Hypertension: Results of the Swiss Isradipine Study (1991) (7)
Frontiers in congenital heart disease: pulmonary hypertension, heart failure, and arrhythmias. (2016) (7)
Renal nerve ablation reduces blood pressure in resistant hypertension: Long‐term clinical outcomes in a single‐center experience (2018) (7)
Novel cardiovascular risk factors: air pollution, air temperature, pain, and sleep duration. (2019) (7)
The collateral damage of COVID-19 to cardiovascular services: a meta-analysis (2022) (7)
Darusentan, a selective endothelin A receptor antagonist, for the oral treatment of resistant hypertension (2010) (7)
Caffeine induces endothelial tissue factor expression via phosphatidylinositol 3-kinase inhibition (2012) (7)
The year in cardiology 2017: acute coronary syndromes (2018) (7)
Response to letter regarding article, “percutaneous left-ventricular support with the impella-2.5-assist device in acute cardiogenic shock results of the Impella-EUROSHOCK registry”. (2013) (7)
Role of vascular endothelial abnormalities in clinical medicine: atherosclerosis, hypertension, diabetes, and endotoxemia. (1994) (7)
[Mechanism of coronary bypass graft disease]. (1993) (7)
The European Heart Journal on the move: can scientific publishing be further improved? (2013) (7)
Multi-vessel revascularization in ST-segment elevation myocardial infarction: where do we stand? (2016) (7)
Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth. (2002) (7)
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelines. (2021) (7)
The NO-donor MPC-1011 stimulates angiogenesis and arteriogenesis and improves hindlimb ischemia via a cGMP-dependent pathway involving VEGF and SDF-1α. (2020) (7)
[Extrarenal fibromuscular hyperplasia with renovascular hypertension (author's transl)]. (1980) (7)
Acute coronary syndromes: mechanisms, reperfusion injury, antithrombotic therapy, and current outcomes. (2016) (7)
Curable renal parenchymatous hypertension: current diagnosis and management. (1985) (7)
Endogenous and exogenous nitrates and their role in myocardial ischaemia. (1992) (7)
Development of Nitrate Tolerance in Human Arteries and Veins: Comparison of Nitroglycerin and SPM 5185 (1995) (7)
Complex cardiac anatomy and catheter access: the role of imaging in patients referred for catheter ablation. (2011) (7)
[Renovascular hypertension in Switzerland 1976-1978. A multicenter study]. (1980) (6)
Pre- and post-operative assessment of valvular and aortic flow using 4D flow magnetic resonance imaging. (2013) (6)
Takotsubo syndrome – A close connection to the brain: A prospective study investigating neuropsychiatric traits (2016) (6)
Cyclosporine C0- versus C2-monitoring over three years in maintenance heart transplantation. (2011) (6)
Extracellular vesicle species differentially affect endothelial cell functions and differentially respond to exercise training in patients with chronic coronary syndromes. (2020) (6)
Patient satisfaction and clinical outcome following outpatient radiofrequency catheter ablation of supraventricular tachycardia. (2010) (6)
Myocardial revascularization: guideline-based therapy today. (2019) (6)
The MAP kinase JNK2 mediates cigarette smoke-induced arterial thrombosis (2016) (6)
Caffeic acid phenethyl ester inhibits endothelial tissue factor expression. (2013) (6)
Effect of pre-treatment with transdermal glyceryl trinitrate on myocardial ischaemia during coronary angioplasty. (1996) (6)
View point: what should the future design of clinical imaging studies be? (2013) (6)
Conflicts of interest and the truth of scientific discovery: an editor's perspective. (2016) (6)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (6)
Management of Patients with Carotid Artery Stenosis (2008) (6)
Cardio-oncology: low-grade inflammation as a common pathway of cancer and cardiovascular disease. (2019) (6)
[Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications]. (1996) (6)
Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial (2020) (6)
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study. (2015) (6)
Global position paper on cardiovascular regenerative medicine Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes ( TACTICS ) international group for the comprehensive cardiovascular application of regenerative medicinal products (2017) (6)
Sports cardiology: towards the sweet spot in competitive and leisure exercise. (2019) (6)
Welcome to the ESC journal family (2012) (6)
Understanding COVID-19: in the end it is the endothelium—what else? (2020) (6)
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial Infarction (2018) (6)
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort. (2019) (6)
Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis (2021) (6)
Association of left bundle branch block with obstructive coronary artery disease on coronary CT angiography: a case-control study. (2016) (6)
Percutaneous retrieval of an endothelialized AMPLATZER cardiac plug from the abdominal aorta 6 months after embolization. (2014) (6)
Valvular heart disease: tricuspid regurgitation is the new frontier. (2018) (6)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (6)
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. (2017) (6)
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease. (2021) (6)
Endothelium-Derived Vasoactive Substances (1988) (6)
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. (2017) (6)
The red and the white, and the difference it makes (2019) (6)
[Stem and progenitor cell-based therapy approaches: current developments on treatment of acute myocardial infarction and chronic ischemic cardiomyopathy]. (2010) (6)
Will endothelin receptor antagonists have a role in heart failure? (2003) (6)
Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound study (1999) (6)
Working together in cardiovascular prevention: the common mission of the European Heart Journal and the European Journal of Preventive Cardiology (2012) (6)
C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis (2006) (6)
Atherosclerosis and CAD. (2015) (6)
Dangerous encounters: triggers of fatal ventricular arrhythmias and safety of interventional treatment strategies. (2018) (6)
Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry (2021) (6)
Electrical and mechanical support in advanced heart failure. Rationale and feasibility of a combined management strategy. (2002) (6)
Short-Term Outcome After Left Main Interventions in Patients Presenting With Acute Coronary Syndrome. (2018) (6)
Endothelium-Dependent Vasoconstriction (1990) (6)
EARTH: EndothelinA Receptor Antagonist Trial in Heart Failure (2001) (6)
Renovascular hypertension: a rare cardiovascular manifestation of the Ehlers-Danlos syndrome. (1987) (5)
Dietary alpha-linolenic acid increases the platelet count in ApoE-/-mice by reducing clearance (2013) (5)
The year in cardiology 2016: acute coronary syndromes. (2017) (5)
Pulmonary hypertension, gender issues, and quality of care. (2016) (5)
Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome (2021) (5)
Prognostic value of mean pulmonary artery pressure in the stable phase after heart transplantation (2017) (5)
The vascular endothelium in hypertension: target and promoter? (2009) (5)
[Weight reduction and blood pressure]. (1982) (5)
[Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication]. (1997) (5)
Pheochromocytoma triggers takotsubo syndrome. (2019) (5)
Geometrically correct three-dimensional optical coherence tomography: first self-expanding bifurcation stent evaluation. (2013) (5)
Immunological markers of frailty predict outcomes beyond current risk scores in aortic stenosis following transcatheter aortic valve replacement: Role of neopterin and tryptophan (2016) (5)
Frontiers in lipid research: lipoprotein(a), apolipoprotein C-III and E, and PCSK9 and inflammation. (2019) (5)
Sex and gender and cardiovascular medicine: impact in diabetes, acute coronary syndromes, and heart failure. (2020) (5)
Device therapy in cardiac disease: a success story. (2015) (5)
Endothelium-dependent regulatory mechanisms in human coronary bypass grafts: possible clinical implications. (1989) (5)
Molecular evidence of Enterococcus faecalis in an occluding coronary thrombus from a patient with late prosthetic valve endocarditis (2012) (5)
No evidence for involvement of the human inducible nitric oxide synthase gene in susceptibility to coronary artery disease (2005) (5)
Peripheral Arterial Occlusive Disease (2009) (5)
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors´ Network. (2017) (5)
TAVI is on the move! How it compares with surgery and what complications we still have to consider. (2019) (5)
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation (2022) (5)
From epicardial coronary arteries to the coronary microcirculation: novel insights into a neglected issue (2017) (5)
[Ultrasonic findings in renal diseases with hypertension (author's transl)]. (2008) (5)
Prognosis of Patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary Syndromes (2019) (5)
Arterial and pulmonary hypertension: risk assessment and current pharmacological and interventional management. (2018) (5)
Oxidized, but not native low density lipoproteins inhibit relaxations of porcine coronary arteries by a scavenger receptor dependent mechanism: Role of endothelium-derived nitric oxide (1991) (5)
17β-Oestradiol inhibits growth of human vascular smooth muscle: Similar effects in cells from females and males (1996) (5)
Estrogen and vascular resistance (1999) (5)
Treatment of stable angina (2000) (5)
Predictors as well as surrogate and hard endpoints in cardiovascular disease. (2015) (5)
Statins Blunt Thrombin-induced Down-regulation of Endothelial Nitric Oxide Synthase Expression in Human Endothelial Cells (2006) (5)
The heart and the brain: cardiovascular risk factors, atrial fibrillation, and dementia. (2019) (5)
The Aging Cardiovascular System (2017) (5)
Data Sharing (2017) (5)
Sport, exercise, and daily activity: a double-edged sword revisited. (2016) (5)
Epigenetic regulation of tissue factor inducibility in endothelial cell senescence (2014) (5)
Dysfunctional HDL and inflammation: a noxious liaison in adolescents with type 1 diabetes. (2019) (5)
Optimal Timing of Invasive Coronary Angiography following NSTEMI (2020) (5)
Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation. (2015) (5)
Tissue Factor Expression Does Not Predict Mortality in Breast Cancer Patients. (2017) (5)
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial (2016) (5)
Primary aldosteronism due to adrenal carcinomas (1984) (5)
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial. (2022) (5)
PCV23 ECONOMIC IMPACT OF CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION (ACS) UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS (PCI): A EUROPEAN OVERVIEW (2003) (4)
LDL-cholesterol targets: perspectives for the use of PCSK9 inhibitors. (2016) (4)
Endogenous Estrogens Increase Postischemic Hyperemia in the Skin Microcirculation (2005) (4)
Safety and efficacy profile of bioresorbable‐polylactide‐polymer‐biolimus‐A9‐eluting stents versus durable‐polymer‐everolimus‐ and zotarolimus‐eluting stents in patients with acute coronary syndrome (2016) (4)
[Renovascular hypertension: comparison between transluminal dilatation and surgical procedures]. (1982) (4)
Research ethics needs fine tuning, not rigidity: how to promote evidence in neglected patient populations by rethinking informed consent. (2015) (4)
Long-term dietary supplementation with plant-derived omega-3 fatty acid improves outcome in experimental ischemic stroke. (2021) (4)
Ejection fraction to classify heart failure: are we using the right thing? (2020) (4)
Inhibition of Vascular c‐Jun N‐Terminal Kinase 2 Improves Obesity‐Induced Endothelial Dysfunction After Roux‐en‐Y Gastric Bypass (2017) (4)
Epidemiology and clinical outcomes. (2015) (4)
Takotsubo syndrome: How the broken heart deals with negative emotions (2019) (4)
Mechanisms and outcomes of heart failure: from HFpEF, HFmrEF, and HFrEF to transplantation. (2018) (4)
Update on interventional cardiology: outcome according to stent type and implantation technique. (2016) (4)
Corrigendum to: PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1. (2021) (4)
Rapid and Body Weight-Independent Improvement of Endothelial and HDL Function After Roux-enY Gastric Bypass : Role of Glucagon-Like Peptide-1 Running title : (2015) (4)
[19] - Nitric Oxide and Endothelial Regulation of Vascular Tone (1996) (4)
Optical coherence tomography to reveal vascular lesions after catheter-based renal nerve ablation with a novel multi-electrode EnligHTN™ system. (2013) (4)
TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies. (2021) (4)
The Asp298 but not the C-786 genotype of the endothelial nitric oxide synthase is reduced with age in healthy Swiss men (2005) (4)
Impact of malignancy on clinical outcomes in patients with acute coronary syndromes. (2020) (4)
Risk factors for and management of heart failure. (2015) (4)
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients. (2021) (4)
Regulation of vascular tone and endothelial function and its alterations in cardiovascular disease (1997) (4)
Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication. (2017) (4)
Outcomes after Transcatheter Aortic Valve Implantation: a Single Center Registry of 350 Consecutive Cases (2013) (4)
Diversity of cardiac patients: An underestimated issue. (2020) (4)
Association between income and control of cardiovascular risk factors after acute coronary syndromes: an observational study. (2019) (4)
Gut microbiota and coronary artery disease (2018) (4)
Functional abnormalities of the vascular endothelium in hypertension and atherosclerosis. (1990) (4)
Risk factors for chronic heart failure: obesity, renal dysfunction, arteriovenous fistulas, and amyloid deposition. (2017) (4)
[Controversy over calcium antagonists: is there a rationally differentiating therapy?]. (1996) (4)
The EHJ: the first years and the future. (2014) (4)
Dysfunction of the Release of Endothelium-Derived Relaxing Factor (1992) (4)
Abstract 5486: High Density Lipoprotein (HDL) From Healthy Subjects, but Not From Patients With Coronary Artery Disease, Exerts Anti-thrombotic Effects on Human Endothelial Cells (2009) (4)
Comprar The ESC Textbook of Cardiovascular Medicine 2nd | Thomas F. Lüscher | 9780199566990 | Oxford University Press (2009) (4)
CANTOS: a seductive song with several verses (2018) (4)
Endothelin Receptor Antagonists as New Tools to Inhibit Endothelin induced Vasoconstriction in Humans: Comparison with Calcium Channel Blockers (1995) (4)
High-sugar feeding and increasing cholesterol levels in infants. (2020) (4)
Oxidized Low-Density Lipoprotein Activates p 66 Shc via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 , Protein Kinase C-, and c-Jun N-Terminal Kinase Kinase in Human Endothelial Cells (2011) (4)
Dietary Alpha-Linolenic Acid Reduces Platelet Activation and Collagen-mediated Cell Adhesion in Sickle Cell Disease Mice. (2021) (4)
From endothelial dysfunction to clinical events Concept and update on the ENCORE trials (2001) (4)
The value of coronary calcium score in daily clinical routine, a case series of patients with extensive coronary calcifications. (2013) (4)
A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery (2004) (4)
Percutaneous closure of patent foramen ovale and valvular function -- effect of the amplatzer occluder. (2012) (4)
Atrial fibrillation: novel risk factors, mechanisms and ablation techniques. (2016) (4)
Medical Misinformation: Vet the Message! (2019) (4)
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events. (2021) (4)
Interventional treatment of essential hypertension: renal sympathetic denervation (2012) (4)
Calcium Antagonists and ACE Inhibitors (2012) (4)
Neurocardiology: the brain-heart connection in Takotsubo syndrome. (2019) (4)
Captopril in various forms of severe therapy-resistant hypertension (1981) (4)
LONG-TERM PROGNOSTIC VALUE OF CARDIAC HYBRID IMAGING INTEGRATING SINGLE-PHOTON-EMISSION COMPUTED TOMOGRAPHY WITH CORONARY COMPUTED TOMOGRAPHY ANGIOGRAPHY (2016) (4)
To stent or not to stent? Treating angina after ISCHEMIA-introduction. (2021) (4)
Short-Term Blood Pressure Variability (2019) (4)
Heart failure with preserved ejection fraction: unravelling an enigma. (2018) (4)
p27(Kip1) inhibits tissue factor expression. (2013) (4)
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) (4)
Endotheliale Dysfunktion und Stickstoffmonoxid (NO; Nitric Oxide) (1997) (4)
[Hypertension and vascular diseases: molecular and cellular mechanisms]. (1995) (4)
Effect of Left Ventricular Conduction Delay on All-Cause and Cardiovascular Mortality (from the PRECISION Trial). (2019) (4)
[Compliance in hypertensive patients and patients with cardiac insufficiency]. (1981) (4)
Alternatively Spliced Tissue Factor Is Not Sufficient for Embryonic Development (2014) (4)
The impact of modern noninvasive cardiac imaging on coronary intervention rates. (2014) (4)
European National Society Cardiovascular Journals. Background, rationale and mission statement of the "Editors' Club". (2008) (3)
"On-site" prevention and education to improve cardiac pre-competition screening in competitive amateur athletes. (2013) (3)
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. (2017) (3)
Holiday heart block: alcohol-induced PR prolongation. (2013) (3)
From heart failure to transplantation: genes, miRNAs, and biomarkers. (2016) (3)
The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation (2021) (3)
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting. (2020) (3)
Substrates of acute coronary syndromes: new insights into plaque rupture and erosion. (2015) (3)
Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum. (2021) (3)
Prognostic value of total testosterone levels in patients with acute coronary syndromes. (2019) (3)
Interventional cardiology: in search of the balance between ischaemia and bleeding. (2015) (3)
Clinical impact of repolarization changes in supine versus upright body position. (2013) (3)
Endothelin antagonists on the clinical horizon in nephrology. (1996) (3)
Falls and Fractures in the Elderly with Sinus Node Disease: The Impact of Pacemaker Implantation (2012) (3)
Personalized approaches to heart failure: age, acute presentation, and comorbidities. (2018) (3)
A broken heart in a broken car. (2016) (3)
[Nitric oxide: the endogenous nitrate in the cardiovascular system]. (1996) (3)
Clinical Manifestations of Atherosclerosis (2012) (3)
Clinical benefits and safety of renal denervation in severe arterial hypertension: A long‐term follow‐up study (2020) (3)
Coronary and peripheral interventions: an update. (2016) (3)
An update on heart failure and peripheral arterial disease. (2015) (3)
Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry (2021) (3)
Methylation of the Hippo effector YAP by the methyltransferase SETD7 drives myocardial ischemic injury: a translational study. (2022) (3)
[Role of nitric oxide in the regulation of the mechanical properties of peripheral muscular arteries in man]. (1995) (3)
Calcium antagonists and endothelial function (1999) (3)
Innate Signalling Promotes Formation of Regulatory Nitric Oxide-Producing Dendritic Cells Limiting T Cell Expansion in Experimental Autoimmune Myocarditis (2013) (3)
Carotid Artery Stenting: A Single Center “Real World” Experience (2012) (3)
Vasopeptidase Inhibitors: A New Class of Drugs (2001) (3)
Rapid and Body Weight-Independent Improvement of Endothelial and HDL Function After Roux-en-Y Gastric Bypass: Role of Glucagon-Like Peptide-1 Running title: Osto et al.; Rapid effects of RYGB on endothelial and HDL function (2015) (3)
The Intercept Blood System Affects Platelet Function and Survival By Inducing Apoptosis (2014) (3)
[Effect of chronic inhibition of nitric oxide synthesis on vascular structure: remodeling or growth?]. (1995) (3)
The role of European National Journals in Education. (2009) (3)
[Clinical-pharmacological case report: drug-induced inappropriate ADH secretion]. (1992) (3)
Intraluminal pressure modulates vascular contractility of perfused mesenteric resistance arteries. Altered response in hypertension. (1992) (3)
[Drug-induced Stevens-Johnson syndrome in a patient with AIDS]. (1993) (3)
Cardiomyopathies: definition, diagnosis, causes, and genetics. (2016) (3)
Nutrition, obesity, diabetes, and cardiovascular outcomes: a deadly association. (2020) (3)
How European cardiologists perceive the role of calcium antagonists in follow-up after myocardial infarction. (1997) (3)
Updates on prevention: obesity, ezetimibe, PCSK9, and HIV infection. (2016) (3)
Atherosclerosis, neoatherosclerosis, and vascular disease. (2015) (3)
Effects of HMG-CoA Reductase Inhibition on Endothelial Function and Lipid Profile in HIV-infected Persons on Protease Inhibitor-containing Antiretroviral Combination Therapy : A Randomized Double-Blind Cross-Over Trial (2005) (3)
Revisiting angina pectoris with and without obstructive coronary artery disease. (2018) (3)
Randomized Trial of Early mTOR Inhibition in Patients with Acute ST-Segment Elevation Myocardial Infarction. (2022) (3)
ST-segment elevation myocardial infarction: the new ESC Guidelines. (2018) (3)
Heart failure: the epidemic of the new century. (2014) (3)
Wine, chocolate, and coffee: forbidden joys? (2021) (3)
Vasopeptidase inhibition and endothelial function in hypertension (2001) (3)
Mechanisms of disease: paracine effects of adipose tissue, progenitor cell function, and epigenetics of diabetic vascular disease. (2015) (3)
Record high EHJ Impact Factor 2016. (2017) (3)
The subcutaneous implantable cardioverter defibrillator in daily clinical practice. (2017) (3)
Transplantation and Tracking of Human Induced Pluripotent Stem Cells in a Pig Model of Myocardial Infarction: Assessment of Cell Survival, Engraftment and Distribution by Hybrid SPECT-CT Imaging of Sodium Iodide Symporter Trangene Expression (2012) (3)
Analysis of the Mechanisms of Increased Platelet Count Induced by Dietary α-Linolenic Acid Indicates Reduced Cleavage of GPIb and Reduced p38 Phosphorylation (2011) (3)
Transluminal dilatation of experimental hydronephrosis in dogs: acute and chronic effects, haemodynamic changes, and histological findings. (1984) (3)
[Is arteriosclerosis an infectious disease?]. (1998) (3)
Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromes. (2021) (3)
Improving outcomes after acute coronary events: what works and what doesn't. (2018) (3)
Introduction: Endothelial control of vascular tone and growth (1993) (3)
Endothelium-mediated signaling and vascular aging (2002) (3)
Novel insights into body fat distribution and cardiometabolic risk. (2019) (3)
Supraventricular and ventricular tachycardias: risk factors, drugs, and ablation. (2017) (3)
Function and Expression of Endothelin-converting Enzyme-1 in Human Vascular Smooth Muscle (1998) (3)
Eminence, common sense, and evidence: a comment to the Andreas Grüntzig lecture 2015. (2016) (3)
[Semi-automatic measurement of blood pressure--how reliable is it? (author's transl)]. (2008) (3)
TAVI: from an experimental procedure to standard of care. (2018) (3)
The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration. (2016) (3)
Outcome of congenital heart disease with modern cardiac care (2018) (3)
[Venous diseases]. (2007) (3)
[European National Society cardiovascular journals. Background, rationale and mission statement of the "editors' club"]. (2008) (3)
Intracoronary beta-irradiation prevents excessive in-stent neointimal proliferation in de novo lesions of patients with high plasma ACE levels. The BetAce randomized trial. (2005) (3)
Improving 1-year mortality prediction in ACS patients using machine learning. (2021) (3)
Improvement in Risk Stratification in Transcatheter Aortic Valve Implantation Using a Combination of the Tumor Marker CA125 and the Logistic EuroSCORE. (2017) (3)
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation (2023) (3)
Severe hypernatremic coma due to diphenylhydantoin intoxication. (1983) (3)
Managing arrhythmias: diagnosis and modern treatment. (2016) (3)
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention (2019) (3)
Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective study (2015) (3)
The Impact Factor: sparkling or still? (2018) (3)
The management of acute coronary syndromes: towards optimal treatment of STEMI and non-STEMI. (2016) (3)
An European Society of Cardiology/European Association of Cardiovascular Imaging task force is examining the appropriate use of cardiovascular imaging in Europe (2014) (3)
EHJ - Cardiovascular Pharmacotherapy: a warm welcome to the new member of the ESC journal family. (2015) (3)
Estrogen inhibits endothelin production in human endothelial cells: evidence for NO-independent, estrogen receptor-mediated mechanisms and thrombin-mediated superoxide release (1998) (3)
'The lower the better' revisited: the new lipid targets in high risk patients. (2020) (3)
Stress – The International Journal on the Biology of Stress Restraint stress enhances arterial thrombosis in vivo Role of the sympathetic nervous system (3)
Cardiovascular Risk Profile, Presentation and Management Outcomes of Patients with Acute Coronary Syndromes after Coronary Artery Bypass Grafting. (2021) (3)
Future directions in the management of chronic angina and ACS - the MERLIN-TIMI 36 trial (2004) (2)
Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals (2012) (2)
Effects of acute administration of trimethylamine N-oxide on endothelial function: a translational study (2022) (2)
Effects of Pycnogenol on Endothelial Function in Patients with Stable Coronary Artery Disease-A Double-blind , Randomized , Placebo-controlled , Crossover Study Pycnogenol improves endothelial function (2017) (2)
Acute coronary syndromes and coronary intervention. (2015) (2)
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. (2017) (2)
Atrial fibrillation and thrombo- embolism: anticoagulants or devices? (2017) (2)
MILD HYPERTENSION: TO TREAT OR NOT TO TREAT? (1983) (2)
Cysteine‐Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes (2021) (2)
Frontiers in cardiac imaging: diagnostic and prognostic validity and safety. (2018) (2)
The endothelium in cardiovascular disease : pathophysiology, clinical presentation and pharmacotherapy (1995) (2)
Commentary and Discussion on the Opening Session Epidemiology, Cardiovascular Aspects, and Analysis of Cocoa Flavanols (2006) (2)
Cardiology in Poland - a European perspective. (2014) (2)
Right coronary artery motion analysis: a novel method to measure right ventricular systolic function by selective coronary angiography (2019) (2)
Clinical and electrocardiographic features of patients with myocardial infarction with non-obstructive coronary artery disease (MINOCA) (2020) (2)
A revolution in diabetes care: novel drugs and new recommendations. (2020) (2)
Ethical Issues--the challenge to keep up with a changing environment. (2016) (2)
Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes. (2019) (2)
Cardio-oncology: a new specialty moves to centre stage. (2019) (2)
[Drug-induced hyperprolactinemia and galactorrhea]. (1992) (2)
Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease (1998) (2)
In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice. (2021) (2)
Endothelial SIRT6 deficiency promotes arterial thrombosis in mice. (2022) (2)
The London PCHF – a new postgraduate course on heart failure (2020) (2)
Tumours and the heart: common risk factors, chemotherapy, and radiation. (2016) (2)
Possibilities and perspectives of pharmacotherapy for endothelial protection. (1993) (2)
Aortic stenosis: expanding treatment options. (2016) (2)
TAVI the frontier of interventional cardiology 40 years after the first ballon angioplasty. (2017) (2)
Takotsubo: a Japanese contribution to cardiology. (2016) (2)
PROGNOSTIC SIGNIFICANCE OF SYNTAX SCORE II IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS INTERVENTION (2015) (2)
Abstract 20401: Cardiorenal Risks of Celecoxib, Naproxen or Ibuprofen in Arthritis Patients : A Sub-Anaylsis From the PRECISION Trial (2017) (2)
ESC CardioMed. (2018) (2)
Cardiac hybrid imaging in a patient with a single coronary artery originating from the right sinus of Valsalva. (2011) (2)
Addition of Omega-3 α-Linolenic Acid to Platelet Apheresis Units Preserves Platelet Activatability Over Time and Reduces Baseline Activation Under Routine Storage Conditions: A Pilot Study (2012) (2)
Abstract 4870: Mechanisms Leading to Impaired Endothelial-vasoprotective Properties of High Density Lipoprotein (HDL) in Patients With Coronary Disease (CAD) (2009) (2)
Inclusion of multiple inappropriate studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome: editor's response. (2019) (2)
Understanding and preventing atherosclerosis: from bench to bedside. (2019) (2)
Pregnancy, rheumatic heart disease, and cardiomyopathies: more on under-recognized entities. (2015) (2)
Ischemic stroke across sexes: what is the status quo? (2018) (2)
Heart failure and left ventricular remodelling in HFrEF and HFpEF. (2016) (2)
Pulmonary embolism and pulmonary hypertension: two issues often neglected in cardiology. (2015) (2)
Arrhythmias and device therapy. (2015) (2)
ENDOTHELIN AND ENDOTHELIN RECEPTOR ANTAGONISTS IN CARDIOVASCULAR DISEASE (1998) (2)
Novel insights in HFpEF, cardiomyopathies, and myocarditis. (2018) (2)
Progress in the management of arrhythmias: risk scores, ablation, and anticoagulation (2018) (2)
Mechanisms of Cardiovascular Aging (2013) (2)
Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study. (2022) (2)
[Vasopeptidase inhibitors. Clinical implications of a new class of drugs]. (2008) (2)
Infections, infarction, and heart failure: prevention and management. (2015) (2)
Improving prevention: risk scores, imaging, and PCSK9 inhibitors. (2016) (2)
[Mechanisms of acute coronary syndrome]. (1995) (2)
Congenital heart disease: some progress, but still the challenge of a lifetime! (2017) (2)
19 Role of endothelium‐derived nitric oxide in flow‐dependent dilation of human peripheral conduit arteries in vivo (1994) (2)
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial (2018) (2)
An update on heart failure: from experimental findings to clinical trials. (2017) (2)
[Blood pressure, renin angiotensin aldosterone system and other cardiovascular risk factors in children of essential hypertensives (author's transl)]. (1982) (2)
Rare forms of renal hypertension (1981) (2)
Outcomes of acute coronary syndromes: clinical presentation, gender, inflammation, and cell therapy. (2017) (2)
Medical Misinformation: Vet the Message! (2019) (2)
The evolving role of left atrial appendage occlusion: a high-volume single-centre experience (2016) (2)
Mitral valve disease, atrial fibrillation, and device therapy. (2015) (2)
Lipoproteins and diabetes. (2015) (2)
Medical misinformation: vet the message! (2019) (2)
Endothelium control of vascular tone and growth: Potential role in coronary artery disease (1994) (2)
Pathophysiology of Intimal Hyperplasia (2000) (2)
Czech contributions to European cardiology—The European Heart Journal's perspective (2013) (2)
[Immune cells in atherosclerosis--good or bad?]. (2016) (2)
Frontiers of Prevention: Pollution, Infection, Cognitive Function and Frailty. (2017) (2)
ANATOMICAL AND PROCEDURAL DETERMINANTS OF CATHETER-BASED RENAL DENERVATION (2016) (2)
Prognostic role of plasma galectin-3 levels in acute coronary syndrome (2020) (2)
Chapter 16 – Endothelium in Hypertension: Nitric Oxide (2005) (2)
[Regulation of aldosterone secretion in anephric patients]. (1981) (2)
[Stress echocardiography: analysis of results in 100 coronary angiography patients]. (2000) (2)
Antioxidants and neuroprotection (2012) (2)
Endothelial Function in Hypertension: Role of Nitric Oxide (1997) (2)
Hyperglycemic Memory Bringing All the Strands Together (2013) (2)
Serotonin and the blood vessel wall. (1986) (2)
‘The lower the better’ revisited: low-density lipoprotein and lipoprotein(a) (2018) (2)
Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3. (2020) (2)
The lifespan determinant p66shc drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation (2013) (2)
Frontiers of valvular heart disease: from aortic stenosis to the tricuspid valve and congenital anomalies. (2017) (2)
[Myocardial revascularization in geriatric patients]. (1997) (2)
Artificial intelligence: the pathway to the future of cardiovascular medicine. (2021) (2)
Heart failure with preserved ejection fraction: towards an understanding of an enigma. (2019) (2)
Abstract 1659: Amphetamines Induce Endothelial Tissue Factor - Role of Dopamine Receptor Type 4 (2008) (2)
Back to square one: what is a normal blood pressure and for whom? (2018) (2)
Hydroxysteroid Dehydrogenase Inhibition : Role of Nitric Oxide β Induced by 11 Endothelin 1 Type A Receptor Antagonism Prevents Vascular Dysfunction and Hypertension (2001) (2)
Challenges in atrial fibrillation: detection, alert systems, fibrosis, and infection. (2020) (2)
Subarachnoid Hemorrhage and Cerebral Vasospasm (1988) (2)
Gender and noninvasive diagnosis of coronary artery disease in women and men. (2003) (2)
Will SPYRAL HTN-ON MED change my practice? SPYRAL HTN-ON MED: a prospective, randomised, sham-controlled trial on renal denervation in the presence of antihypertensive medications. (2018) (2)
Congenital heart and aortic disease: novel genetic causes, biomarkers, and effect of pregnancy. (2018) (2)
Local regulation of vascular tone and growth. (1994) (2)
Aging and longevity genes p66shc and junD mediate age-related dysfunction of angiogenic early outgrowth cells: mechanistic insights into vascular repair (2013) (2)
Haemodynamic tracing pattern reveals acute type A aortic dissection (2012) (2)
An adult with congenital aortic coarctation (2001) (2)
Cholesterol production, accumulation, reverse transport, and excretion: opportunities for statins, PPAR-α agonists, and PCSK9 inhibitors. (2015) (2)
"Real world" experience in Cardiac Resynchronization Therapy at a Swiss Tertiary Care Center. (2017) (2)
Risk factors and consequences of atrial fibrillation: genetics, blood pressure, working hours, and cognitive decline. (2017) (2)
Dual antiplatelet therapy: how, how long, and in which patients? (2018) (2)
Frontiers in precision medicine: genes and their modulation by miRNAs. (2016) (2)
Cardiovascular diseases outside the heart: novel recommendations for pulmonary embolism and peripheral arterial disease. (2020) (2)
[Practical implementation of intravenous pyelography in the evaluation of hypertension]. (1983) (2)
Obituary: John T. Shepherd, MD, MChir., DSc. (2012) (1)
Historical Account: Interventional Cardiology (2013) (1)
Therapeutic MMP-2 knockdown blunts age-dependent carotid stiffness by decreasing elastin degradation and augmenting enos activation (2021) (1)
Inflammation and acute coronary syndromes (ACS) - a clinical research network funded by the Swiss National Science Foundation (2010) (1)
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes. (2022) (1)
Lipids and lipid lowering: current management with statins and PCSK9 inhibitors (2018) (1)
Abstract 18317: Abnormal High Density Lipoprotein (HDL) from Patients with Chronic Kidney Disease (CKD) Increases Arterial Blood Pressure: Role of Toll-Like Receptor-2 (TLR-2) (2012) (1)
Update on hypertension: target blood pressure, comorbidities, and outcome. (2016) (1)
[Role of endothelium in the etiology and therapy of atherosclerosis]. (2000) (1)
Herztod in den Bergen (2019) (1)
Acute myocardial infarction after botulinum toxin injection. (2011) (1)
Acute coronary syndromes: early diagnosis, management, and risk prediction (2017) (1)
Assessing myocardial ischaemia in epicardial coronaries and the microcirculation. (2018) (1)
The role of European national journals in education. (2009) (1)
Abstracts selected for presentation at the XXIII Congress of the European Society of Cardiology, together with the 36th Annual General Meeting of the Association for European Paediatric Cardiology (AEPC), September 1–5,2001, Stockholm, Sweden (2001) (1)
The next chapter of prevention: from LDL-cholesterol to lipoprotein(a) and triglycerides. (2020) (1)
Deletion of the AP-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates Age-Related Endothelial Dysfunction (2013) (1)
[Long-term effect of weight reduction in patients with hypertension and normal blood pressure]. (1984) (1)
Chapter 17 – Circulation (2000) (1)
Abstract 15090: Coronary Computed Tomography Provides Local SYNTAX Scores for Complex Culprit Lesions Correlating with Angiography (2011) (1)
Abstract Not Available) (2010) (1)
464Optimal timing of invasive coronary angiography following NSTEMI (2019) (1)
Between Scylla and Charybdis: combining anticoagulants with platelet inhibitors and outcome. (2019) (1)
[Postoperative course in primary aldosteronism]. (1982) (1)
An update on cardiomyopathies: immune-mediated diseases, sarcoidosis, and peripartum and hypertrophic cardiomyopathies during pregnancy. (2017) (1)
ROUX–EN–Y GASTRIC BYPASS IMPROVES OBESITY–INDUCED ENDOTHELIAL DYSFUNCTION BY A GLUCAGON LIKE PEPTIDE–1 MEDIATED BODY WEIGHT LOSS INDEPENDENT EFFECT (2013) (1)
[Gene therapy in heart diseases]. (1999) (1)
Steak and eggs: eat in moderation. (2019) (1)
Hypertension: detection, mechanisms, outcomes, and treatment. (2017) (1)
Production, characterization and clinical application of antisera to cortisol. (1983) (1)
Medical misinformation: Vet the message! (2019) (1)
Improving outcome in acute coronary syndromes: ischaemic conditioning, antithrombosis and bleeding, and inflammasome antagonism. (2017) (1)
Research Day of the Royal Brompton and Harefield Hospitals, Royal Society of Medicine, London. (2020) (1)
Diagnosis of CHF – Often a Trap in Itself (2000) (1)
Endocarditis: the Cinderella of Cardiology is back! (2019) (1)
Rapid Inflammasome Activation Is Attenuated in Post-Myocardial Infarction Monocytes (2022) (1)
Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer. (2023) (1)
Prevention: from molecular mechanisms to novel risk factors and patient management. (2016) (1)
[Therapy of endocrine-active adrenal cortex carcinoma]. (2008) (1)
Perioperative care of cardiac patients: preventing myocardial injury, bleeding, and death. (2017) (1)
Prolyl-isomerase-1 (pin1) mediates hyperglycemia-induced oxidative stress, endothelial function and vascular inflammation: insights in patients with type 2 diabetes (2013) (1)
Natural Course of Paravalvular Regurgitation After Implantation of the Self-Expanding CoreValve: Insights From Serial TEE Measurements. (2015) (1)
Acute rupture of a thin cap fibroatheroma: value of multimodality imaging. (2015) (1)
Optimal management of syncope: the new ESC Guidelines and novel insights into its underlying causes (2018) (1)
Typical and atypical acute coronary syndromes: inflammation, vasoconstriction, and dissection as major mechanisms. (2020) (1)
Acute coronary sydromes: the impressive impact of guideline-based management in NSTEMI. (2018) (1)
[Drug-eluting stents: breakthrough or time bomb]. (2007) (1)
Cardiac hybrid imaging guides revascularization prior to non-cardiac surgery. (2013) (1)
Endothelin: culprit or bystander in Addison's disease? (1996) (1)
The role of European National Journals in education. (2009) (1)
Coronary stent thrombosis in acute coronary syndromes (2018) (1)
Aortic valve and aneurysms. (2015) (1)
Frontiers of interventional cardiology: plaque imaging, thrombus load, and bifurcation lesions. (2016) (1)
Cardiorenal Risk of Celecoxib compared to Naproxen, or Ibuprofen in Arthritis Patients: Insights from the PRECISION trial. (2022) (1)
Aquaporin-1: a major modulator of aging-mediated platelet/endothelial dysfunction in atherothrombosis (2020) (1)
Pathology and Pathogenesis of Renovascular Hypertension (1992) (1)
Single-vessel versus multivessel PCI in patients with acute coronary syndrome and multivessel coronary artery disease (2011) (1)
Frontiers of lipid research: cholesterol variability, HDL biogenesis, genetics of myalgia, and lipoprotein(a). (2017) (1)
The European Heart Journal and EuroIntervention: information and education in interventional cardiology. (2013) (1)
[Basic evaluation and therapy of hypertension. Implementation and results in a polyclinical patient sample]. (1983) (1)
Managing stable coronary artery disease: drugs, PCI, or devices (2018) (1)
[An incidental finding of renal cysts: routine occurrence or a finding deserving clarification?]. (1987) (1)
A Comparative Study Between 100mg Atenolol and 20mg Pindolol Slow-Release in Essential Hypertension (1983) (1)
Catheter ablation for atrial fibrillation in a real-world setting (2015) (1)
Hypertension: an undertreated known risk factor revisited. (2019) (1)
Atrial fibrillation: from biomarkers to CABANA. (2019) (1)
Abstract 16655: Role of PKC{beta}II/p66Shc Pathway As A Determinant Of Metabolic Memory In Human Endothelial Cells (2010) (1)
Distinct dietary alpha-linolenic acid-dependent shifts in the fecal microbiome composition suppresses aging-associated inflammatory responses and thrombus formation (2020) (1)
In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. (2017) (1)
Treating lipid disorders and diabetes with novel and established drugs. (2015) (1)
[Renovascular hypertension: surgery, dilatation or drugs?]. (1985) (1)
Frontiers in the management of coronary artery disease: bioabsorable scaffolds, regenerative medicine, and gene therapy. (2017) (1)
Coronary and peripheral artery remodeling in patients undergoing PTCA: An intracoronary and transcutaneous ultrasound study. (1999) (1)
[Alcohol and hypertension]. (1984) (1)
Medical Misinformation. (2019) (1)
Frontiers in cardiovascular prevention (2018) (1)
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE). (2021) (1)
Abstract 15156: Myoglobin is a Strong Predictor of Extent of Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in Patients With Acute Myocarditis (2017) (1)
Nitric oxide inhibits proliferation of human aortic vascular smooth muscle cells: role of cell cycle regulatory proteins (1998) (1)
Abstract 12438: Vascular Hyperglycemic Memory is Abolished by in-vivo Silencing of the Mitochondrial Adaptor p66Shc (2011) (1)
Reproducibility of ambulatory blood pressure mea- surement in patients with coronary heart disease (2014) (1)
Dyslipidaemias: new mechanistic insights and the 2016 ESC Guidelines. (2016) (1)
The London PCHF: A new Postgraduate Course on Heart Failure. (2019) (1)
GENDER-RELATED OUTCOMES IN ELDERLY (> 75 YEARS) PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROMES: RESULTS FROM THE SWISS ACUTE CORONARY SYNDROME COHORT (2017) (1)
Methylation of the hippo signalling effector YAP by SETD7 drives myocardial ischemic injury (2020) (1)
ESC CardioMed – the new electronic ESC Textbook of Cardiovascular Medicine (2018) (1)
Are there differences in the renal effects of selective cyclo-oxygenase 2 inhibitors? (2006) (1)
Novel insights in HFrEF and HFpEF: patient characteristics, remote monitoring, and management. (2016) (1)
[Quality and integrity in the production and publication of scientific results: data trimming, manipulation and (self) plagiarism]. (2014) (1)
Coronary and structural interventions: novel evidence for decision making. (2018) (1)
Extracellular vesicle species differentially affect endothelial cell functions and differentially respond to exercise training in patients with chronic coronary syndromes. (2021) (1)
Stroke: cardiac causes and their management. (2015) (1)
Channelopathies and sudden cardiac death: genetics and pharmacological triggers. (2019) (1)
Endothelium and Hemostasis in Health and Disease (2008) (1)
[Blood pressure differences in both arms. Results of serial and simultaneous blood pressure measurement]. (1983) (1)
The year in cardiology 2016: acute coronary syndromes (2017) (1)
European National Society Cardiovascular Journals. Background, rationale and mission statement of the "Editors' Club" (Task Force of the European Society of Cardiology). (2009) (1)
Forgotten cardiovascular risk factors: pregnancy complications and preterm birth, bullying, periodontal disease, and hypoxic burden. (2019) (1)
Abstract 19862: HDL Stimulates Endothelial CAT-1 Expression and L-Arginine Uptake: A Novel Mechanism Leading to Endothelial-Protective Effects of HDL That is Profoundly Altered in Patients With Coronary Disease (2010) (1)
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors´ Network (2017) (1)
Nifedipine inhibits superoxide production induced by pulsatile stretch in human aortic endothelial cells (2000) (1)
The role of matrix metalloproteinase-2 on age-dependent arterial stiffness (2020) (1)
Clinical Pharmacists' Effect on Drug Information Requests (1996) (1)
Heart failure and its causes: high blood pressure, atrial fibrillation, radiotherapy, and chemotherapy (2018) (1)
Secondary causes of hypertension (2018) (1)
Letter by Winnik et Al regarding article, "conversion of cardiovascular conference abstracts to publications". (2013) (1)
[Fibromuscular renovascular hypertension: comparison of surgery, transluminal dilatation and drug therapy]. (1985) (1)
Long-Term Experience in Percutaneous Transluminal Dilatation of Renal Artery Stenosis (1986) (1)
Arrhythmias and their management in long QT, ARVC, and atrial fibrillation. (2019) (1)
Heart failure: focus on co-morbidities, inflammation, and heart rate. (2015) (1)
[The vascular endothelium as mediator and target organ of cardiovascular diseases]. (1988) (1)
Diagnosis of CHF — often a trap In Itself (2000) (1)
[Transesophageal echocardiography: indications and findings. Experiences from 3 centers]. (2008) (1)
P736Histone marks induced by the methyltransferase SETD7 modulate angiogenic response in diabetes (2019) (1)
Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity. (2019) (1)
Coronary heart disease Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease : a double-blind , randomized , placebo-controlled , cross-over study (2012) (1)
Severe left main coronary stenosis and mitral regurgitation in a young female patient without cardiovascular risk factors 14 years after mediastinal radiation therapy (2010) (1)
38. Endogenous endothelin stimulated by angiotensin II augments contractility of hypertensive resistance arteries (1991) (1)
Cutting edge research on transcatheter aortic valve implantation: moving indications, complications, and current outcomes. (2018) (1)
Optical coherence tomography to reveal strut malapposition due to thrombus resolution 3 weeks after acute coronary syndrome. (2013) (1)
Endothelial function and the effects of aldosterone blockade (2011) (1)
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). (2023) (1)
Of stiff and weak ventricles. (2015) (1)
1431Modulation of JunD by miR-494-3p causes intra-myocardial lipid accumulation and obesity cardiomyopathy: a study in mice and humans (2018) (1)
Abstract 18661: Endothelial Effects of High-Density Lipoprotein (HDL) Remain Impaired Following Dalcetrapib Treatment in Patients with Coronary Artery Disease or Risk Equivalent (2012) (1)
Lipids and vascular function (1995) (1)
Functional impairment of visually non- or minimally atherosclerotic coronary arteries Insight from the ENCORE trial (2000) (1)
Sudden cardiac death: addressing unresolved issues. (2020) (1)
To do or not to do? Changing paradigms: value of balloon-sizing and left atrial appendage occlusion (2014) (1)
Endothelium-Dependent Responses in Human Arteries and Veins (1990) (1)
CHARACTERISTICS AND SPECIFIC ECG FINDINGS IN 200 PATIENTS WITH STRESS-INDUCED “TAKOTSUBO” CARDIOMYOPATHY COMPARISON BETWEEN TYPICAL AND ATYPICAL FORMS (2015) (1)
COVID-19: (mis)managing an announced Black Swan (2020) (1)
Intravenous ferric carboxymaltose improves quality of life in patients with chronic heart failure and iron deficiency regardless the presence of anaemia: an analysis from the FAIR-HF study (2010) (1)
Valvular heart disease: improved procedural success and prediction of outcomes. (2020) (1)
Sirtuin 5 promotes arterial thrombosis through endothelial plasminogen activator inhibitor-1 (2020) (1)
Circulation and hemodynamics. (1994) (1)
Percutaneous implantation of an ASD occluder with intracardiac ultrasound (2010) (1)
Microvesicles released from activated CD4+ T cells alter microvascular endothelial cell function (2022) (1)
Frontiers in heart failure: assessement, risk factors, and novel genetic and cell-based therapies. (2016) (1)
Novel molecular mechanisms of vascular disease: non-coding RNAs, inflammation, and radiation. (2019) (1)
[Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance]. (1982) (1)
Myocardial Infarction and Coronary Vasospasm (1988) (1)
Captopril in Cushing's syndrome (1984) (1)
They eat, what we eat, they digest, what we ingest: The Microbiome and the Vulnerable Plaque. (2020) (1)
[Role of nitric oxide in flow-dependent vasodilation of human peripheral arteries in vivo]. (1994) (1)
Calcification Characteristics of Low-Flow Low-Gradient Severe Aortic Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement (2015) (1)
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitors. (2020) (1)
Abstracts selected for presentation at the European Society of Cardiology Congress 31 August–4 September 2002, Berlin - Germany (2002) (1)
Increased plasma Glucagon Like Peptide-1 improves endothelial dysfunction immediately after Roux-en-Y gastric bypass prior to body weight loss inhibiting the c-Jun N-terminal Protein Kinase Signaling (2013) (1)
[Heart, brain and hypertension]. (1996) (1)
Interventional therapy for hypertension: Back on track again? (2017) (1)
Vascular Function in Hypertension: Role of Endothelium-Derived Factors (2005) (1)
Sports cardiology: the benefits of cardiorespiratory fitness in young adults, the elderly, and patients with arrythmias. (2020) (1)
Risk assessment and management of myocardial infarction. (2016) (1)
Prognostic value of total testosterone levels in patients with acute coronary syndromes. (2021) (1)
CALCIUMANTAGONISTEN IN DER KONTROVERSE : GIBT ES EINE RATIONALE DIFFERENTIALTHERAPIE ? (2008) (1)
Antioxidants and Endothelial Function: Human Studies (2006) (1)
Classification of heart failure: A farewell to ejection fraction? (2020) (1)
A simple and effective method to teach patients about high blood pressure and obesity. (1985) (1)
Acetyltransferase gene non-derepressible 5 mediates hyperglycemia-induced endothelial oxidative stressin patients with type 2 diabetes (2013) (1)
[Hypertension in unilateral (non-vascular) nephrosclerosis: renin activity in the venous kidney blood and effect of nephrectomy]. (1979) (1)
Managing aortic stenosis with TAVI or surgery: risk assessement and long-term outcome. (2017) (1)
Therapy: Part I Diabetes and Vascular Disease : Pathophysiology, Clinical Consequences, and Medical (2012) (1)
Managing acute coronary syndromes: from novel biomarkers to mechanical support devices and DAPT in thrombocytopenia (2017) (1)
[Endothelial dysfunction and nitrogen monoxide (NO; nitric oxide)]. (1997) (1)
Endothelium-dependent responses in human blood vessels in health and cardiovascular disease (1991) (1)
Refining cardiovascular risk: anthropometric measures, potassium, high altitude exposure, and cancer therapy. (2018) (1)
The expanding spectrum of acute coronary syndromes: from STEMI to coronary dissection and Takotsubo syndrome. (2019) (1)
Towards individualized lifetime risk: combining classical and non-classical factors. (2020) (1)
[Receptor-mediated endothelial vascular regulation (brief report)]. (1994) (1)
Deletion of hepatic NCOR1 confers atheroprotection (2020) (0)
Corrigendum to “Falls and Fractures in the Elderly with Sinus Node Disease: The Impact of Pacemaker Implantation” (2017) (0)
Catheter-based management of valvular heart disease: from TAVI to Mitraclip, Cardioband, and tricuspid interventions. (2019) (0)
Neue Schweizer Fellows der European Society of Cardiology (2015) (0)
The Spectrum of ACS: Towards a More Personalized Approach (2021) (0)
Paul M. Vanhoutte (1940-2019) MD PhD hon. mult. (2019) (0)
Authors’ Response. (2016) (0)
Gender Differences in Types, Frequency, Clinical Manifestations and Atherosclerotic Burden of Coronary Artery Anomalies. (2019) (0)
Abstract 11343: High Density Lipoprotein (HDL) From Patients with Early Kidney Disease (CKD) Exerts Adverse Endothelial Effects (2011) (0)
Current management of supraventricular tachycardias: the 2019 ESC Guidelines. (2020) (0)
Long-term dietary n3 fatty acid prevents aging-related cardiac diastolic and vascular dysfunction. (2023) (0)
Serotonin, the Endothelium and the Coronary Circulation (1991) (0)
Novel prognostic markers and treatment options in heart failure: from palliative to regenerative medicine. (2015) (0)
Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality (2019) (0)
Acute coronary syndromes and sudden cardiac death in the modern era (2017) (0)
Abstract 77: Endothelial LOX-1 Protects Against Arterial Thrombosis via Activation of the Oct-1/SIRT1 Pathway (2014) (0)
Abstract 17492: Vitamin D Improves Endothelial Function In Experimental Hypertension (2012) (0)
Modulation of the hippo pathway by SETD7 regulates myocardial ischemia-reperfusion injury (2020) (0)
Smoking cessation and depression after acute coronary syndrome. (2022) (0)
From systemic and pulmonary hypertension to heart failure: novel drugs and devices. (2017) (0)
Risk assessement and its management: from SCORE to statins, ezetimibe to PCSK inhibitors. (2017) (0)
Ischaemic and genetic causes of fatal arrhythmias and sudden death. (2019) (0)
[Physiologic and pathophysiologic functions of nitric oxide in circulation]. (1994) (0)
P919Clinical characteristics of patients with cancer and takotsubo cardiomyopathy - Observations from the international takotsubo registry (2018) (0)
Heart failure - Oxford Medicine (2019) (0)
European health-care systems: a new CardioPulse series. (2012) (0)
Anticoagulation in clinically difficult situations: insights into safe and effective management (2018) (0)
Paul M. Vanhoutte (1940-2019) MD PhD hon. mult. (2019) (0)
Looking deeper into takotsubo heart. (2022) (0)
Frontiers in heart failure: sodium, longitudinal strain, contractility sensor, fatal arrhythmias, and stroke. (2017) (0)
1190 Basal and midventricular balloning: new patterns of transient left ventricular ballooning? (2006) (0)
Transient Ischaemic Attack and Stroke (2021) (0)
Grown-up congenital heart disease: building evidence where it is badly needed. (2019) (0)
[Endocrine-active adreno cortical carcinoma: clinical forms and differential diagnosis]. (2008) (0)
Scientific statement of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) international group for the com- prehensive cardiovascular application of regenerative medicinal products (2018) (0)
Intravenous Drug€Use–Associated Endocarditis Complicating Research of Antibiotic Prophylaxis and Guideline Recommendations (2019) (0)
O167 Pharmacological Sirt1 Activation In Apoe-/- Mice Provides Atheroprotection By Reducing Hepatic Pcsk9 Secretion And Enhancing Ldl-R Expression (2014) (0)
216-52: Adverse Effects of Elevated Testosterone and Low Estradiol Serum Levels on Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (2016) (0)
[Transesophageal echocardiography in the diagnosis of endocarditis]. (1994) (0)
Preoperative Screening Prior to Non-Cardiac Surgery (2021) (0)
2nd International Symposium on Endothelium-Derived Vasoactive Factors (Part 2 of 11) (1992) (0)
[Sympathy and heartache: new information on the sympathetic nervous system]. (1997) (0)
Global Cardiovascular Risk (2021) (0)
HEART Group meeting. (2018) (0)
[Doppler analysis of blood flow of the supratrochlear artery: age specific pattern analysis in healthy and hypertensive patients]. (1984) (0)
The Year in Cardiology series: the most recent advances in a nutshell for the readers of the European Heart Journal. (2013) (0)
Outcome of Percutaneous Patent Foramen Ovale Closure with the Premere Occluder – A Single Center Experience (2014) (0)
NEP/ACE Inhibitors: Experimental and Clinical Aspects (2004) (0)
Aging, Oxidative Stress, and Cardiovascular Disorders (2010) (0)
Abstract 16519: Epigenetic Remodeling of Nox2 by Acetyltransferase Gcn5 Drives Hyperglycemia-Induced Endothelial Oxidative Stress (2013) (0)
Cardiovascular complications in CKD 5D (2012) (0)
Syncope and sudden cardiac death: some answers to clinical challenges. (2016) (0)
Valvular heart disease: new risk factors and new challenges. (2017) (0)
EHJ at the American Heart Association: a Transatlantic View. (2017) (0)
Abstract 15986: Systematic Cardiac Magnetic Resonance Imaging in Patients With Angina-Like Symptoms and Elevated Troponin Levels Suggests Existing Protocols May Lead to Underdiagnosis of Myocarditis (2017) (0)
Sudden cardiac death: new aspects of a continuing clinical challenge (2017) (0)
Coronary optical frequency domain imaging ( OFDI ) for in vivo evaluation of stent healing : comparison with light and electron microscopic analysis (2009) (0)
'The lower the better' revisited: the new lipid targets in high risk patients. (2020) (0)
HFpEF: an enigma being slowly but surely unravelled. (2019) (0)
56-04: Myocardial expression of non-desmosomal molecules in arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to dilated cardiomyopathy and healthy controls (2016) (0)
Some Thoughts from Your Publisher (2001) (0)
Imaging and outcomes in cardiac, valvular, and peripheral arterial disease. (2016) (0)
11th International Symposium on Mechanisms of Vasodilation (2013) (0)
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after study. (2022) (0)
The balance between nitric oxide and free radicals affects the coronary vasodilator reserve (1999) (0)
From TAVI to tricuspid cliping: fine-tuning the management of valvular heart disease. (2020) (0)
Smoking and Cessation (2021) (0)
Mo-P2:200 C-reactive protein enhances shear stress-dependent platelet adhesion (2006) (0)
Causes of death in renal disease (2018) (0)
TCT CONNECT-267 BIOVITESSE—Multicenter Prospective First-In-Man Study of a New Polymer-Free Drug-Coated Stent With Ultrathin Struts: Clinical Study Outcome (2020) (0)
Prevention Summit 2018 (2018) (0)
Neglected cardiovascular risk factors. (2015) (0)
Abstract 4121: Effect of Dark Chocolate on Coronary Vasomotion in Patients after Heart Transplantation (2006) (0)
' s response to reviews Title : Diagnostic accuracy of point-of-care testing for acute coronary syndromes , heart failure and thromboembolic events in primary care : a cluster-randomised controlled trial (2010) (0)
Data sharing: A new editorial initiative of the International Committee of Medical Journal Editors. Implications for the editors’ network☆ (2017) (0)
Breaking news in heart failure: ESC Guidelines 2016, non-steroidal mineralocorticoid receptor antagonist, and alternate site CRT pacing. (2016) (0)
MP354SYMMETRIC DIMETHYLARGININE, HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE (2017) (0)
Abstract 12056: Inducible Ventricular Tachycardia Predicts Long-Term Adverse Outcome in Arrhythmogenic Right Ventricular Cardiomyopathy (2012) (0)
Prevention of non-communicable diseases and special causes of heart failure. (2015) (0)
Recovery mismatch between myocardial blood flow and cardiac workload after physical exercise: a positron emission tomography study. (2014) (0)
Bone marrow-specific Sirt 6 deficiency enhances atherosclerosis by increasing Macrophage scavenger receptor 1 expression (2021) (0)
[The prevalence of hypertension in patients with roentgenologic signs of pyelonephritis in intravenous pyelography]. (1981) (0)
CardioPulse: Sensing the cardiovascular world. (2009) (0)
The European Heart Journal in Barcelona (2009) (0)
The spectrum of cardiomyopathies: novel insights into hypertrophic, arrythmogenic, and amyloid phenotypes. (2019) (0)
Differences of Vascular Remodeling in Human Coronary Artery Bypass Vessels (2009) (0)
Acute coronary and cerebrovascular syndrome. (2016) (0)
Abstract 5577: Complement Component 3a Receptor (C3aR) Attenuates Atherosclerosis Development (2009) (0)
Medical Misinformation - Vet the Message! (2019) (0)
How are you (2010) (0)
[Antithrombotic therapy in acute coronary syndromes]. (2009) (0)
Abstract 563: Myeloid Related Protein 8 is a Ligand of Toll-like receptor 4 in Acute Coronary Syndromes (2008) (0)
P1222Intensification of lipid lowering therapy before and after publication of the IMPROVE-IT trial: A temporal analysis from the SPUM-ACS cohort (2019) (0)
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammation. (2022) (0)
Endothelin (1991) (0)
Myocardial injury and myocardial infarction: the various ways of losing myocytes and their prognostic impact. (2019) (0)
Subject Index Vol. 1, 2001 (2001) (0)
Clinical trials in interventional cardiology: a challenging necessity. (2020) (0)
Atrial fibrillation and stroke: anticoagulation in trials and real-world settings (2018) (0)
ApoA-I mimetics improve aortic stenosis-associated left-ventricular diastolic dysfunction but fail to benefit rabbit models with normal aortic valves. (2021) (0)
[Acute dyspnea]. (1996) (0)
Historical Account Cardiology (2018) (0)
Atrial fibrillation and arrhythmias: novel risk assessment, proper anticoagulation, and ablation. (2018) (0)
P1941The nuclear receptor corepressor 1 blocks CD36-mediated foam cell formation in atherogenesis (2019) (0)
Update on heart failure: biomarkers, intensive therapy, remote monitoring, and cardiomyocyte renewal. (2017) (0)
The role of European national journals in education. (2009) (0)
Nitrates and the Role of the Endothelium (1993) (0)
Telomerase Activity in Human Endothelial Cells Fibroblast Growth Factor-2 , But Not Vascular Endothelial Growth Factor , Upregulates (2003) (0)
[Significance of the vascular endothelium in heart surgery]. (1988) (0)
ConfliC t of interest poliCies and dis Closure requirements among european s oCiety of Cardiology national Cardiovas Cular journals (2012) (0)
Abstract 12263: The Role of Glucagon-Like Peptide-1 in the Immediate Improvement of Endothelial-Protective HDL Functions After Roux-en-Y Gastric Bypass in Obese Patients (2014) (0)
The role of P2Y12 receptor antagonists in thrombogenesis (2019) (0)
PERCUTANEOUS TRANSSEPTAL MITRAL VALVE-IN-VALVE AND VALVE-IN-RING PROCEDURE IN HIGH-RISK PATIENTS: PROCEDURAL AND EARLY OUTCOMES IN THE VENETO REGION (2019) (0)
Is ACE Inhibition the Standard of Care for Management of Coronary Artery Disease (2000) (0)
European National Society Cardiovascular Journals. Background, rationale and mission statement of the "Editors' Club" (Task Force of the European Society of Cardiology). (2008) (0)
Paul M. Vanhoutte, pioneer of cardiovascular biology and mentor of numerous fellows worldwide dies in Paris (2019) (0)
Novel aspects of heart failure: from combined neurohormal blockade to embryonic stem cells. (2015) (0)
[Captopril in treatment-resistant hypertension (author's transl)]. (1980) (0)
Transplantation Statins and the Risk of Cancer After Heart Transplantation (2012) (0)
Modernes Lipid-Management (2020) (0)
Assessing coronary plaques: non-invasive and intracoronary imaging and haemodynamic measurements. (2018) (0)
Frontiers of surgical and catheter-based management of valvular heart disease. (2019) (0)
P715Deletion of fibroblast activation protein decreases experimental atherosclerotic plaque formation and vulnerability (2019) (0)
Coronary sinus reducer device for patients with refractory angina (2018) (0)
[Cardiovascular disease in pregnancy]. (1999) (0)
European National Society Cardiovascular Journals. Background, rationale and mission statement of the "Editors' Club" (Task Force of the European Society of Cardiology). (2008) (0)
Cardiology Update London 2017 (2018) (0)
Cardiogenic Shock : Results of the Impella Assist Device in Acute − Percutaneous (2013) (0)
3.P.6 Rapid vascular of superoxide dismutase involve nitric oxide, Cu2+ and binding to endothelial cells (1997) (0)
Medical Misinformation. (2019) (0)
Diabetes mellitus und metabolisches Syndrom – kardiovaskuläre Implikationen (2011) (0)
Mechanisms: psychological factors and outcomes (2018) (0)
4th European Live summit on retrograde chronic total occlusion revascularization. (2015) (0)
Endothelium Function in Human Coronary Bypass Grafts (1991) (0)
Epigenetic analysis of TREG/CD3+ T cell ratio in stemi patients – association with adverse cardiovascular events (2020) (0)
Other Relaxing Substances Released by the Endothelium (2020) (0)
Abstract 2601: Increased TLR-4+ Monocytes in Thrombi from the Site of Coronary Occlusion in Acute Coronary Syndromes - a Role for Innate Immunity in Acute Coronary Syndrome (2007) (0)
Methods to Study Endothelium-Dependent Responses (2020) (0)
Abstract 12566: Insulin Resistant Mice Lacking p66Shc Gene are Protected Against Endothelial Dysfunction (2011) (0)
A new deputy editor for Cardiovascular Medicine (2018) (0)
Acute coronary syndromes: the tipping point of coronary artery disease (2018) (0)
Cardiology Update London 2018 (2019) (0)
[A heart without overspeed trip unit]. (2014) (0)
The coronary circulation: plaques, collaterals, and the microcirculation. (2015) (0)
RENAL FUNCTION POST TAVI, A SIGNIFICANT PREDICTOR OF MORTALITY: INTRODUCING THE ACEF-7 SCORE (2016) (0)
The new postgraduate course in heart failure. (2014) (0)
Platelet-vessel wall interaction in health and disease. Role of thromboxane A2 and serotonin (1992) (0)
Conflict of interest policies and disclosures in Journals (2012) (0)
Arterial Hypertension (2021) (0)
Chromatin modifications by the methyltransferase SETD7 modulate angiogenic response in diabetes: Insights for epigenetic-based therapies (2020) (0)
PosterKidney and hypertensionSelective COX-2 inhibitors and renal injury in salt-sensitive hypertension (2005) (0)
[And Virchow was right nevertheless....]. (2004) (0)
[Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. (1996) (0)
Atrial fibrillation: overall cardiovascular risk beyond stroke and current management. (2018) (0)
SIRT1 activator SRT3025 provides atheroprotection in ApoE/ mice by increasing hepatic LDL receptor (2019) (0)
The saga continues: is COVID-19 a cardiopulmonary disease? (2020) (0)
smooth muscle cells in vivo Adeno-associated virus vector transduction of vascular (2015) (0)
[Accidental adrenal gland tumors: clinical significance and practical management]. (1989) (0)
[The lying Baron as patient or problems in the diagnosis of artificial diseases]. (1984) (0)
arly-and Long-Term Intravascular ltrasound and Angiographic Findings fter Bioabsorbable Magnesium Stent mplantation in Human Coronary Arteries on (0)
Abstract 169: Genetic Deletion of JunD Enhances Age-Associated Endothelial Dysfunction (2006) (0)
Abstract 246: Anacetrapib Adds to the Antiatherogenic Effect of Atorvastatin, Mainly by Increasing the Clearance of Non-HDL Cholesterol (2014) (0)
Frontiers in valvular heart disease. (2016) (0)
Abstract 915: Deletion of JNK2 Prevents Hypercholesterolemia-Induced Oxidative Stress and Endothelial Dysfunction (2007) (0)
JNK INHIBITION IMPROVES OBESITY-INDUCED ENDOTHELIAL DYSFUNCTION AND OXIDATIVE STRESS MIMICKING THE BENEFICIAL EFFECTS OF ROUX-EN-Y GASTRIC BYPASS SURGERY (2015) (0)
Acute myocardial infarction: triggers, interventional management, and outcomes (2017) (0)
Arrhythmias and pacing. (2015) (0)
Prevention: From Lifestyle Changes to Medication. (2018) (0)
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in Switzerland (2021) (0)
[Long-term therapy of hypertension in a general practice: 1950--1980 (author's transl)]. (1982) (0)
First three-dimensional optical frequency domain imaging evaluation of a bioabsorbable vascular scaffold implantation in an instent-restenosis 6 years after CYPHER stenting. (2014) (0)
P2510Insufficient smoking cessation in patients with diabetes after acute coronary syndrome, need for improved secondary prevention (2018) (0)
Abstract 411: High Density Lipoprotein (HDL) Loses Endothelial-protective Effects in Patients with Stable Coronary Disease and Acute Coronary Syndrome: Implications for HDL-targeted Therapies (2008) (0)
Activation of the tissue endothelin system in severe polyglobulia (2002) (0)
Clinical results in a single tertiary care center Catheter ablation for atrial fibrillation in a real-world setting (2015) (0)
CKD NUTRITION, INFLAMMATION AND OXIDATIVE STRESS (2014) (0)
2182Sirtuin 5 regulates arterial thrombosis by modulating endothelial plasminogen activator inhibitor-1 (2019) (0)
Atrial fibrillation: today's guideline-based management. (2016) (0)
A Model of Platelets in the Aging Organism Reveals Increased Numbers Due to Reduced Clearance and Enhanced Activatability of Gp2b/3a and P-Selectin, Resulting in a Larger Stroke Burden (2016) (0)
1045-189 Plaque targeting in atherosclerotic mice using a small immunoprotein against an angiogenesis-associated fibronectin isoform (2004) (0)
Title Page / Contents / Foreword / Preface / Acknowledgements (1988) (0)
[Comment from the cardiologic viewpoint]. (2009) (0)
OP-EHEA180074 2032..2046 (2018) (0)
Abstract 19027: Influence of Intravenous Ferric Carboxymaltose on Health-Related Quality of Life Measures in Patients with Chronic Heart Failure and Iron Deficiency: an Analysis from the FAIR-HF Study (2010) (0)
Dialysis / Cardiovascular complications (2011) (0)
The secret of success of heart failure therapy: A lesson for ACHD? (2020) (0)
Cardiovascular Computed Tomography (2009) (0)
The novel sirt1 activator srt3025 provides atheroprotection through increased hepatic low-density lipoprotein receptor expression (2013) (0)
Anti–Tumor Necrosis Factor-&agr; Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis (2002) (0)
Correction: Carotid Artery Stenting: A Single Center “Real World” Experience (2012) (0)
Arrhythmias, syncopy, and sudden death. (2015) (0)
Frontiers in valvular heart disease: outcomes of novel percutaneous procedures. (2020) (0)
The role of European national journals in education. (2009) (0)
Optimizing management of atrial fibrillation: integrated care, blood pressure control, ablation, and left atrial appendix occlusion. (2020) (0)
The new Editorial Board starts with a focus issue on thrombosis: a key player in many cardiovascular diseases (2020) (0)
Interventional cardiology: successes and failures. (2015) (0)
Network-Guided Multiomic Mapping of Aortic Valve Calcification. (2023) (0)
What is the optimal blood pressure? Differences between current guidelines and novel insights into kidney injury. (2019) (0)
Diabetic Vascular Disease (1988) (0)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022) (0)
Production of Contracting Agents (2020) (0)
, Cells Limiting T-Cell Expansion in Experimental Autoimmune Myocarditis Producing Dendritic − Innate Signaling Promotes Formation of Regulatory Nitric Oxide (2013) (0)
Management of patients undergoing percutaneous vascular interventions: balancing ischaemic benefit and bleeding risk. (2017) (0)
EHJ's new impact factor of 15.2: a global strategy is paying off. (2015) (0)
The ESC publications committee: scope, successes, and challenges 2009-20. (2020) (0)
Cardiology Update 2017—an ongoing success story (2017) (0)
Controversy of calcium antagonists: is there a rational differential therapy? (1996) (0)
Nervous System The Beauty and the Beast : Aspects of the Autonomic (2000) (0)
Be more, do more, research more: The importance of developing local science (2020) (0)
Thomas F. Lüscher is the 6th Annual Krakoff International Lecturer in Cardiovascular Medicine (2014) (0)
Cardiac pre-competition screening in Swiss athletes Current situation in competitive athletes and short follow-up assessment of an exemplary local screening programme (0)
Title Page (2013) (0)
Heart failure: drugs, surgery, and assist devices. (2018) (0)
Heart failure / cardiomyopathy Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy (2014) (0)
MS359 DAL-VESSEL – A RANDOMISED, PLACEBO-CONTROLLED STUDY OF DALCETRAPIB ON ENDOTHELIAL FUNCTION, AS MEASURED BY FLOW MEDIATED DILATATION, IN HIGH-RISK PATIENTS (2010) (0)
TORCETRAPIB IMPAIRS ENDOTHELIAL FUNCTION IN HYPERTENSION: 4D.03 (2011) (0)
Sudden Cardiac Death of an Unusual Kind: Spontaneous Coronary Artery Dissection in Young Women. (2023) (0)
Diversity of cardiac patients: An underestimated issue (2020) (0)
Bone marrow-specific Sirt6 deletion increases atherogenesis by increasing macrophage scavenger receptor 1 (2016) (0)
Chronic coronary syndromes: expanding the spectrum and natural history of ischaemic heart disease. (2020) (0)
2162Neurofibromin 2 (NF2) drives obesity-related endothelial dysfunction by targeting Caveolin-1: a study in mice and humans (2019) (0)
From bench to bedside: the clinical future on the horizon of experimental evidence. (2017) (0)
Management of arrhythmias: NOACs, digoxin, alcohol, light, and devices. (2017) (0)
Abstract 13780: JNK Inhibition Mimics the Beneficial Effect of Roux-en-Y Gastric Bypass Surgery on Obesity-Induced Endothelial Dysfunction (2014) (0)
TCT-625 The ECG after transcatheter aortic valve implantation determines the need for pacemaker implantation and the required duration of telemetry monitoring (2015) (0)
Abstract 11798: The Nitric Oxide-Donor MPC-1011 Stimulates Angiogenesis and Arteriogenesis and Improves Hindlimb Ischemia via a cGMP-dependent Pathway Involving VEGF and SDF-1 Alpha (2017) (0)
The Biomedical Alliance Spring Meeting on Plan S. (2019) (0)
Very, very British (2018) (0)
From conventional to molecular imaging: delineating mechanisms, diagnosis, and outcomes. (2017) (0)
Important news from the European Heart Journal for 2013 Into the future on the shoulder of past achievements (2012) (0)
Filling a gap in the ESC Journal Family: a warm welcome to the EHJ - Quality of Care and Clinical Outcomes. (2015) (0)
Paul M. Vanhoutte, pioneer of cardiovascular biology and mentor of numerous fellows worldwide dies in Paris. (2019) (0)
[Left-ventricular hypertrophy and left heart insufficiency: towards cause-oriented therapy]. (1996) (0)
Honesty and Truth in Academic Research and Writing (2019) (0)
Chronic coronary syndromes: genetics, shear stress, and biomarkers. (2019) (0)
Abstract 4941: Dietary Alpha-Linolenic Acid Supplementation Inhibits Thrombus Formation in vivo (2009) (0)
Paul M. Vanhoutte dies in Paris aged 79 (2019) (0)
Gerd Hindricks moves on. (2017) (0)
P3178Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry (2018) (0)
Multiple postpartal coronary artery dissections and fibromuscular renal artery dysplasia. (2008) (0)
Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting. (2019) (0)
Prof. Thomas F. Lüscher, Editor in Chief of The European Heart Journal (2012) (0)
Circulating Long Noncoding RNA Signatures Associate With Incident Diabetes in Older Adults: a Prospective Analysis From the VITA Cohort Study. (2023) (0)
Abstract 17546: Effect of Intravenous Ferric Carboxymaltose on Symptoms and Quality of Life in Iron-Deficient Patients With Chronic Heart Failure With and Without Anemia: A Sub-Analysis of the FAIR-HF Trial (2010) (0)
DIFFERENTIAL EFFECTS OF SELECTIVE COX-2 INHIBITORS ON ENDOTHELIAL FUNCTION IN SALT-INDUCED HYPERTENSION: 8A.5 (2004) (0)
Biology of bypass vessels and their relation to patency and disease (2021) (0)
O 06 Sirtuin 5 regulates arterial thrombosis by modulating endothelial plasminogen activator inhibitor-1 (0)
["Under pressure" -- the clinical relevance of hypertension for the heart and circulation]. (2006) (0)
Frontiers of acute coronary syndromes: primary PCI time window, 15-year outcomes, bleeding and MINOCA. (2020) (0)
A chromatin signature by the methyltransferase SETD7 regulates semaphorin-3G transcription and angiogenic response in diabetes: insights for personalized epigenetic therapies (2020) (0)
Abstract 539: P66Shc Adaptor Protein Protects From Short-Term Ischemic Myocardial Injury via Intracellular Salvage Pathways (2014) (0)
Takotsubo syndrome: the Cinderella compared with common acute coronary syndromes. (2018) (0)
Endothelial Dysfunction after Angioplasty: A Pathway for Remodelling? (1997) (0)
[Clinical aspects, pathophysiology and diagnosis of artificial metabolic diseases]. (1984) (0)
JCAD promotes arterial thrombosis through PI3K/Akt modulation: a translational study. (2022) (0)
Abstract 16477: Targeting Prolyl-isomerase-1 Protects Against Hyperglycemia-induced Endothelial Dysfunction and Vascular Inflammation: Alterations in Patients With Type 2 Diabetes (2013) (0)
Abstract 5198: Histamine H1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low Density Lipoproteins (2009) (0)
Cardio-oncology and the future of heart failure. (2020) (0)
An update on interventional cardiology: management of CTO, performance of absorbable scaffolds, coronary vasomotion after DES, and antithrombotics. (2016) (0)
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes. (2022) (0)
Abstract 1951: Histamine H1 Receptor is Required for Atherogenesis (2008) (0)
Abstract 16442: Reprogramming of p66Shc and JunD Improves Age-Related Dysfunction of Angiogenic Early Outgrowth Cells (2013) (0)
Nitric oxide and endothelin as mediators of atherosclerosis (1999) (0)
Managing acute coronary syndromes: troponin and DAPT in the real world. (2016) (0)
Heart failure and left ventricular remodelling in HFrEF and HFpEF patients (2016) (0)
The mismanagement of hypertension: doctor's and patient's factors. (1984) (0)
Preventive cardiology in adolescents and the elderly: LDL, HDL, and inflammation. (2019) (0)
The growing spectrum of cardiomyopathies: risk assessment and management. (2019) (0)
P 195 Increased activity of constitutive nitric oxyde synthase in the porcine ciliary body (1995) (0)
TCT-257 Frequency and clinical impact of prasugrel cessation after primary PCI in STEMI patients: a prospective cohort study (2015) (0)
Europe reaches out to Africa New collaborations between the European Heart Rhythm Association and the Cardiac Arrhythmia Society of South Africa / Pan African Society of Cardiology (2016) (0)
Contents of Volume 74 (2000) (2000) (0)
NUTRITION , INFLAMMATION AND OXIDATIVE STRESS-CKD 1-5 SAP 261 OXIDATIVE STRESS AND SYSTEMIC INFLAMMATION AS IMPORTANT COMPONENTS OF CARDIAC VALVE CALCIFICATION IN PREDIALYSIS PATIENTS (2012) (0)
[Assessment of coronary heart diseases or the pitfalls of choice as the primary task]. (1997) (0)
P3477Role of glucagon-like peptides and glucagon in the control of vascular function (2017) (0)
Hypertension is on the move! The new ESC Guidelines and more (2018) (0)
826-2 Interleukin-6 but not C-reactive protein is elevated at the site of ruptured plaques in acute coronary syndromes (2004) (0)
Coronary and cerebrovascular interventions. (2016) (0)
Frontiers in today's chronic coronary syndromes: detecting obstructive disease, role of beta-blockers and of anticoagulants. (2019) (0)
Imaging the left ventricle: diagnostic and prognostic implications in cardiomyopathies. (2019) (0)
Frontiers of acute coronary and aortic syndromes: outcomes, novel prognostic markers, and cardiogenic shock. (2019) (0)
Medical Misinformation. (2019) (0)
TAVI is on the move! Results in low-risk patients, those with mitral disease, and those with cerebral protection. (2019) (0)
2nd International Symposium on Endothelium-Derived Vasoactive Factors (1992) (0)
Abstract 18398: Time Course of Cardiac Markers During Acute Myocarditis (2017) (0)
Acute decrease in kidney function after acute coronary syndromes predicts future bleeding and cardiac death (2020) (0)
EFFECT OF PATENT FORAMEN OVALE CLOSURE DEVICE ON AORTIC AND TRICUSPID VALVE FUNCTION (2010) (0)
Abstract 15937: Abnormal Left Ventricular Conduction is Associated With Increased Cardiovascular Mortality Compared to Abnormal Right Ventricular or Normal Conduction: Insights From the Precision Trial (2017) (0)
Coronary artery disease: risk factors, haemodynamic significance, anatomic complexity, and platelet lipidome. (2017) (0)
Cardiology update 2011: An ESC update programme davos Switzerland, 13-18 February 2011 (2011) (0)
Imaging the heart and the brain: from the amygdala to arterial inflammation. (2020) (0)
Reconstituted high-density lipoprotein restores endothelial function in acute coronary syndrome (2003) (0)
[Electrolyte balance in arterial hypertension (continuation)]. (1980) (0)
Dizziness and pre-syncope: an unusual clinical presentation of a spontaneous coronary artery dissection as revealed by optical coherence tomography. (2011) (0)
P5421Cardiorenal risk of celecoxib compared to naproxen, or ibuprofen in arthritis patients: a sub-analysis of the PRECISION trial (2018) (0)
Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice (2023) (0)
NO and Hypertension (1997) (0)
Risks and management of cardioversion and catheter ablation in atrial fibrillation. (2019) (0)
A systems biology approach towards novel biomarkers of atherosclerosis and validation of fatty acid-binding protein 4 (FABP4) as prognostic and diagnostic biomarker for coronary artery disease (2015) (0)
Gene therapy at the clinical horizon? (2000) (0)
Mitral valve disease: news from the frontier in valvular heart disease (2018) (0)
Abstract 15155: Nonsteroidal Anti-Inflammatory Drug Use in Acute Myopericarditis is Associated With Decreased Late Gadolinium Enhancement at 3 Months Follow-Up (2017) (0)
Cardiology Update India 21: a growing Indio-European educational platform to fight cardiovascular disease. (2021) (0)
Single ventricle / total cavopulmonary connection ( Fontan circulation ) (2019) (0)
The future of scientific publishing. (2019) (0)
Prevention in high-risk patients: a long-term committment. (2015) (0)
Understanding cardiovascular disease: macrophage function, LDL-receptor trafficking, and C-type natriuretic peptide. (2020) (0)
[Setting the switches properly. Interview by Dr. Klaus Reinhardt]. (1997) (0)
Response to Letter Regarding Article, "Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease" (2011) (0)
Neurohumoral Regulation (2020) (0)
Abstract 3741: Stress Promotes Arterial Thrombosis through Activation of the Sympathetic Nervous System (2008) (0)
The ESC Board 2020–2022 (2020) (0)
Supraventricular and ventricular arrhythmias. (2015) (0)
The internist and the vessel wall. (1997) (0)
Frontiers in lipid research: mechanisms, diet, and novel lipids. (2016) (0)
Peripheral arterial disease guidelines: the Cinderella of cardiovascular medicine gets the attention it deserves (2018) (0)
ROLE OF GALECTIN 3, NGAL AND CYSTATIN C IN RISK ASSESSMENT IN THE SETTING OF ACUTE CORONARY SYNDROME (2018) (0)
The Annual Scientific Congress of the Swiss Society of Cardiology in Baden, Switzerland, June 7–9, 2017 (2017) (0)
Shc Protein Final Common Molecular Pathways of Aging and Cardiovascular Disease : Role of the Print (2008) (0)
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]. (2018) (0)
Towards personalized prevention in special patient populations. (2015) (0)
[Electrolyte balance in arterial hypertension]. (1980) (0)
Imaging as a basis of clinical decision-making in congenital and coronary disease and heart failure. (2016) (0)
[Blood-pressure self recording: application and clinical value in the long-term treatment of hypertensives]. (1982) (0)
Arrhythmias and sudden cardiac death: substrates, monitoring, and prevention. (2017) (0)
Medical misinformation: vet the message! (2019) (0)
A PCI LIVE Course where it all began: The 4th European Live Summit on Retrograde Chronic Total Occlusion Revascularization at the Andreas-Grüntzig-Catheterization Laboratories on May 8-9, 2015 (2015) (0)
Contents, Vol. 72, Supplement 1, 1985 (1985) (0)
Cardiovascular issues in women: expanding diversity in medicine. (2019) (0)
Tissue-type plasminogen activator relaxes humam coronary and mammary arteries: A new endothelium-derived relaxing factor? (1990) (0)
FIMICS: A panel of long noncoding RNAs for cardiovascular conditions (2023) (0)
Clinical News. (2017) (0)
Progress in Biomedical Research Closed Loop Stimulation : A Comparison between Inotropic State Index and Muscle Sympathetic Nerve Activity (0)
Paradoxical Increase in Myocardial Perfusion After Nitric Oxide Synthase Blockade (1998) (0)
Prof. Dr. Peter U. Weidmann, FRCP, 1937-2013 (2013) (0)
An update on arrhythmias: mechanisms and novel devices. (2017) (0)
History of peripheral artery disease and cardiovascular risk of real-word patients with acute coronary syndrome: Role of inflammation and comorbidities. (2023) (0)
Cardiology Update Davos 2019. (2019) (0)
Abstract 2436: The Human Antibody against the C Domain of Tenascin-C images Murine Atherosclerotic Plaques ex vivo (2006) (0)
[The Economization of Medicine: Is Medicine a Business?] (2020) (0)
[High blood pressure]. (2006) (0)
THE FUNCTIONAL RELEVANCE OF HIGH DENSITY LIPOPROTEIN STRUCTURE AND COMPOSITION IN THE IMPROVEMENT OF CHOLESTEROL EFFLUX CAPACITY AFTER ROUX-EN-Y GASTRIC BYPASS (2017) (0)
Dysfunction of nitric oxide synthase and endothelium dependent relaxations in tetrahydrobiopterin deficient mice (1997) (0)
Lipid Disorders (2021) (0)
Summer School "Inflammation and Cardiovascular Disease" (2011) (0)
Adverse epigenetic remodelling of p66shc gene correlates with persistent endothelial dysfunction and oxidative stress in type 2 diabetics with optimal glycemic control (2013) (0)
ENDOTHELIN AND ENDOTHELIN AND RENAL DISEASE (1996) (0)
867-3 Peroxynitrite inactivates Akt pathway and enhances tissue factor expression in thrombin stimulated endothelial cells (2004) (0)
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation (2012) (0)
Going backwards: Lifestyle in younger cardiac patients. (2023) (0)
Andreas-Grüntzig Lecture of the Swiss Society of Cardiology 2013 (2013) (0)
[Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions]. (1997) (0)
Dietary Alpha-Linolenic Acid Does Not Protect From Venous Thrombosis In The Vena Cava Stenosis Model (2013) (0)
Imaging and prevention. (2015) (0)
Chronic Heart Failure (2021) (0)
High-sensitivity Troponins - Difficult Friends in Acute Coronary Syndromes (2012) (0)
Estrogen and vascular resistance (Endocrine Hypertension) (2006) (0)
Imaging, prevention, and rehabilitation. (2015) (0)
Continuing Medical Education Activity in Echocardiography (2014) (0)
P5378The methyltransferase SETD7 promotes myocardial ischemic injury by activating Hippo signalling (2019) (0)
Swiss cardiologist elected chairman of the Europen Society of Cardiology (ESC) congress programme committee (2018) (0)
Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer (2022) (0)
Circulation: a new initiative (2005) (0)
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study and for the IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416) (2015) (0)
Accuracy of dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease in patients with reduced ejection fraction (2020) (0)
What happened this year in heart failure? Moving towards a more individualized approach. (2019) (0)
Effects of Chronic Eta-Receptor Blockade in Stroke-Prone Spontaneously Hypertensive Rats. (2000) (0)
OP-EHEA180073 2047..2062 (2018) (0)
Aggravation of focal cerebral ischemia by tissue-plasminogen activator is reversed by rosuvastatin – role of endothelial NO synthase (2004) (0)
P2494Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in ischemia/reperfusion-induced cerebral injury (2018) (0)
Role of Nitric Oxide in the Microcirculation (2000) (0)
reducing clearance mice by − / −-linolenic acid increases the platelet count in ApoE α Dietary (2013) (0)
Aldosterone Receptor Antagonism Normalizes Vascular Function in 11β-Hydroxysteroid Dehydrogenase Deficient Hypertension (2000) (0)
The ESC Textbook of Cardiovascular Medicine wins the 2019 British Medical Association award (2019) (0)
Contents Vol. 123, 2012 (2013) (0)
Fritz R. Bühler, a giant in hypertension research, dies at age 77. (2017) (0)
Prevention et traitement de la formation de thrombus (2005) (0)
Correction to: Looking deeper into takotsubo heart. (2022) (0)
Pericardial and myocardial disease. (2015) (0)
[The Heart and Brain -- a clinically significant situation relationship]. (2008) (0)
P2094The AP-1 member JunD drives cardiac steatosis via transcriptional activation of peroxisome proliferator-activated receptor gamma: insights into obesity cardiomyopathy (2017) (0)
How to slice the pie: heart failure subgroups and their clinical meaning. (2020) (0)
Safety of Prasugrel Loading Doses inPatients Pre-Loaded With ClopidogrelintheSetting of Primary Percutaneous Coronary Intervention (0)
High blood pressure: new frontiers of an old risk factor. (2017) (0)
[Factitious hypoglycemia: clinical aspects, diagnosis and course in a non-diabetic male]. (1982) (0)
Local Regulation of Endothelium-Dependent Responses (2020) (0)
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories. (2019) (0)
Rapid Fire Abstract Session : Epidemiology and Management of CV Risk Factors (0)
Deciding on coronary intervention: which lesion, which stent? (2015) (0)
The challenge of risk estimation in cardiovascular prevention. (2017) (0)
Response to Letter Regarding Article, “Angiotensin-Converting Enzyme Inhibition Improves Vascular Function in Rheumatoid Arthritis” (2008) (0)
FastTrack: a key success factor for the European Heart Journal. (2014) (0)
3.E.2 The role of endothelial function in the pathogenesis of atherosclerosis (1997) (0)
[Cocoa, chocolate--from temptation to remedy?]. (2008) (0)
Refining the management of acute coronary and aortic syndromes. (2019) (0)
[Torsade de pointes during anti-arrhythmia treatment with amiodarone]. (1993) (0)
Erratum: Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemia (European Journal of Nuclear Medicine and Molecular Imaging (2005) 32 (84-91) DOI: 10.1007/s00259-004-1621-y) (2005) (0)
Post-ischemic in vivo p66shc silencing as a therapeutical strategy for ischemia/reperfusion brain injury (2013) (0)
The coronary artery as a living organ. (1998) (0)
[Endocarditis: a clinical challenge]. (1994) (0)
Medical Misinformation. (2019) (0)
Medical misinformation: vet the message! (2019) (0)
Soluble LOX-1 and its interplay with hs-CRP predict poor cardiovascular survival in acute coronary syndromes: A multicentre prospective cohort study (2021) (0)
Analysis of Admission Electrocardiographic Patterns in Survivors and Non-Survivors of Unprotected Left Main Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (2014) (0)
Low-density lipoprotein: the culprit. From evidence to counselling, drugs, and vaccination. (2017) (0)
P533The functional relevance of HDL structure and composition in the improvement of cholesterol efflux capacity after Roux-en-Y gastric bypass (2018) (0)
Preventing coronary artery disease, stroke, and aortic valve disease (2018) (0)
Application of a sex-specific GRACE score in practice – Authors' reply (2023) (0)
Dietary omega-3 fatty acid reverses age-linked heart failure with preserved ejection fraction (2021) (0)
056 Mutli-dimensional prevention program after acute coronary syndrome (ELIPS) (2010) (0)
[Transesophageal echocardiography: technique, indications and findings]. (1992) (0)
Leaders in Cardiovascular Research: Thomas Lüscher. (2019) (0)
OR-53: HMG-CoA reductase inhibitor improves endothelial dysfunction in mineralocorticoid hypertension by inhibition of RhoA (2003) (0)
Catheter-based and surgical interventions in cardiac and aortic conditions. (2016) (0)
Glycogen Synthase Kinase-3 Mediates Endothelial Cell Activation by Tumor Necrosis Factor- (cid:1) (2005) (0)
Friday, 5/19, Mercury Ballroom, 5:00 pm–7:00 pm Theme I: Endothelial and Physical Factors in Hypertension - ENDOTHELIAL FACTORS IN THE CARDIOVASCULAR SYSTEM (1995) (0)
Endothelial Dysfunction and Hypertension (2003) (0)
The renin-angiotensin system and vascular protection : proceedings of a satellite symposium to "Endothelium-Derived Vasoactive Factors," 2nd International Symposium held in Basel, Switzerland, April 23, 1992 (1993) (0)
René A. Lerch steps down as editor-in-chief: A farewell to a great colleague (2016) (0)
Novel risk markers and mediators in coronary disease and stroke. (2015) (0)
Prevention: further insights on age and lipids. (2017) (0)
Heterogeneity and Chronic Modulation (2020) (0)
Unilateral (Curable) Renal Parenchymatous Hypertension (1992) (0)
Atrial fibrillation: still an issue. (2014) (0)
Medical Misinformation. (2019) (0)
Performance of modern stents in stable and acute coronary disease. (2018) (0)
AV Block on Exertion: Pulmonary Sarcoidosis with Involvement of the His-Purkinje System. (2015) (0)
Frontiers in cardiovascular computed tomography: FFRCT, CT/PET, and radiation exposure. (2018) (0)
Could endothelial dysfunction be a surrogate end point for coronary artery disease (2010) (0)
Age-Related Endothelial Dysfunction Deletion of the AP-1 Transcription Factor JunD Induces Oxidative Stress and Accelerates (2013) (0)
From Cinderella to centre stage: valvular heart disease on the move. (2017) (0)
Telomere Length Is Reduced In Endothelial Progenitor Cells (EPCs) from Subjects with Prehypertension and Hypertension and Relates to Impaired Epc In Vivo Re-Endothellalisation Capacity (2008) (0)
Swiss Heart Foundation Research Prize 2020 (2020) (0)
In search of optimal blood pressure. (2019) (0)
A Diet Rich in Alpha-Linolenic Acid Diminishes Atherosclerosis in Apolipoprotein E-Deficient Mice and Reduces Arachidonic Acid in Red Cell Membranes (2008) (0)
[Renal denervation: long-term Swiss experiences]. (2015) (0)
[Endothelin-induced vasoconstriction in man: variable modification caused by endothelium-derived relaxing factor, Sodium nitroprusside and calcium antagonists]. (1992) (0)
Further steps in the TAVI revolution. (2016) (0)
Paul M. Vanhoutte (1940–2019) MD PhD hon. mult. (2019) (0)
Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders. (2016) (0)
Mitral valve disease and acute coronary syndromes. (2015) (0)
Coronary heart disease Myeloid-related protein 8 / 14 complex is released by monocytes and granulocytes at the site of coronary occlusion : a novel , early , and sensitive marker of acute coronary syndromes (2007) (0)
Abstract 16527: Epigenetic Signatures of p66Shc Promoter Contribute to Persistent Endothelial Dysfunction in Type 2 Diabetics With Optimal Glycemic Control (2013) (0)
Endothelium-Derived Relaxing Factor (2020) (0)
Precision medicine in the management of cardiomyopathies (2017) (0)
Introduction (1945) (0)
P169Eligibility for PCSK9 inhibitors according to ESC/EAS and ACC recommendations after acute coronary syndromes (2017) (0)
Stem cell therapy: from translational hurdles to new frontiers. (2017) (0)
Arrhythmias: drugs and devices. (2015) (0)
Remote Ischemic Preconditioning (2013) (0)
1008-187 Effect of pravastatin on endothelial function in human immunodeficiency virus-infected persons on protease inhibitor-containing antiretroviral combination therapy (2004) (0)
A giant right-sided heart due to idiopathic pulmonary hypertension (2013) (0)
Cardiology Update Davos: a remarkable tradition of postgraduate teaching in cardiovascular medicine (2019) (0)
Aortic valve disease 2016: evaluation for and outcome of TAVI and surgery. (2016) (0)
Treatment of patients with chronically occluded coronary arteries (2018) (0)
Acute coronary syndromes Contemporary registries on P 2 Y 12 inhibitors in patients with acute coronary syndromes in Europe : overview and methodological considerations (2015) (0)
Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy. (2017) (0)
Medical Misinformation. (2019) (0)
The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG. (2019) (0)
Acute Myocardial Infarction: Effects on Global Left Ventricular Function Derived Mononuclear Cells Early or Late After - Intracoronary Injection of Bone Marrow (2013) (0)
They eat what we eat, they digest what we ingest. (2023) (0)
Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study. (2022) (0)
Enzyme In Vivo : Evidence for a Regulatory Role of Endothelin Obesity Is Associated With Tissue-Specific Activation of Renal Angiotensin-Converting (2000) (0)
Controversies in interventional cardiology: eminence, common sense, and evidence. (2016) (0)
CardioPulse Articles. (2016) (0)
Abstract 15160: Coronary Computed Tomography Angiography Predicts Complexity of Percutaneous Coronary Interventions (2011) (0)
JNK2 INHIBITION IMPROVES OBESITY INDUCED ENDOTHELIAL DYSFUNCTION AND OXIDATIVE STRESS AFTER ROUX-EN-Y GASTRIC BYPASS (2017) (0)
Unanswered questions in hypertension: prematurity and long-term trajectories, masked and white coat hypertension. (2020) (0)
Modern prevention: genetic testing, vascular imaging, machine learning, and drug safety. (2017) (0)
Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality. (2019) (0)
Endothelial protective properties of HDL improve early after roux-en-y gastric bypass but not after diet-induced weight loss: the superior cardiometabolic benefits of RYGB (2016) (0)
From prevention to plaque rupture and infarction. (2015) (0)
P2260Long-term durability and hemodynamic performance of a self-expanding transcatheter heart valve beyond 5 years after implantation: a prospective observational study applying the standardized definition (2018) (0)
Smoking cessation in people with and without diabetes after acute coronary syndrome. (2022) (0)
The year in cardiology: acute coronary syndromes (2020) (0)
The European Heart Journal: Again, Number One in Cardiovascular Medicine! (2018) (0)
Contents Vol. 1, 2001 (2001) (0)
888-6 Differential effects of selective COX-2 inhibitors on endothelial function in salt-induced hypertension (2004) (0)
Marked coronary endothelial dysfunction in patients with low high-density lipoprotein and elevated C-reactive protein (2003) (0)
Joint Communication from Davos Cardiology Update, February 2017 (2017) (0)
Effect of long-term oral betablocker treatment on myocardial blood flow and coronary flow reserve in CAD-patients assessed with PET (2002) (0)
Clinical outcomes in STEMI patients undergoing percutaneous coronary interventions later than 48 hours after symptom onset. (2023) (0)
Abstract 10509: Aquaporin 1 Differentially Controls Endothelial Cell Senescence by Epigenetic and SASP Modulation (2021) (0)
Clinical Features and Outcomes of Patients With Malignancy (2020) (0)
DUAL ANTIPLATELET THERAPY AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROMES (2014) (0)
[A slide program on hypertension and obesity: a simple method of patient information]. (1983) (0)
Peripheral and pulmonary artery disease: an update on under-regognized cardiovascular issues. (2019) (0)
Acute and chronic coronary syndromes: coronary dissection, intraplaque haemorrhage, and late lumen loss. (2018) (0)
Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66 shc Gene Cellular Biology (2006) (0)
Coronary Artery and Coronary Artery Bypass Graft Disease: Role of the Endothelium and Vascular Smooth Muscle (1993) (0)
Vascular medicine: the Cinderella of cardiology back on stage. (2020) (0)
Troponin: the basis of decision-making in suspected acute coronary syndromes and beyond. (2016) (0)
Abstract 2526: Fetal Programming of Hypertension: Decreased Compliance and IGF-I Plasma Levels in Umbilical Arteries of Infants with Intrauterine Growth Restriction (2007) (0)
DIE TREND-STUDIE (TRIAL ON REVERSING ENDOTHELIAL DYSFUNCTION) (1997) (0)
723-3 Endothelin in the Skin Microcirculation of Patients with Coronary Heart Disease: Effect of Endothelin Antagonist and Calcium Antagonist (1995) (0)
The role of p66 deletion in age-associated arterial dysfunction and disease states (2008) (0)
Data sharing : implications for the Editors ’ Network (2017) (0)
Calcium antagonists. Results of recent studies and their significance for general practice. (1999) (0)
[Quality control of medical care of hypertension]. (1983) (0)
Choice of Imaging Techniques (2009) (0)
Promotion of Zhihong Yang to Full Professor at the University of Fribourg (2017) (0)
An unusual appearance of a pacemaker lead. (2013) (0)
Is Atherosclerosis a No NO State? • Response (2011) (0)
Paul M. Vanhoutte, pioneer of cardiovascular biology and mentor of numerous fellows worldwide dies in Paris. (2019) (0)
Novel insights into rare cardiomyopathies: arrhythmogenic cardiomyopathy, non-compaction, and transthyretin amyloidosis. (2020) (0)
Endothelial factors in the cardio-vascular system (1995) (0)
Professor Willibald Maier. (2020) (0)
[Dangerous reduction of blood flow in the internal mammary artery in acute hypovolemia]. (1990) (0)
Medical Misinformation: Vet the Message! (2019) (0)
Subject Index, Vol. 72, Supplement 1, 1985 (1985) (0)
Catch me if you can. (2014) (0)
Special issues in heart failure: pulmonary hypertension, deranged potassium levels, and haemodynamic profiles. (2017) (0)
Issue @ a glance. (2014) (0)
Noise, pollution, food, or medication: what really matters in primary prevention? (2019) (0)
In memoriam: Prof. Dr. Fritz R. Bühler (2017) (0)
Hyperglycemia-induced myocardial oxidative stress and inflammation persist despite optimal glycemic control: role of mitochondrial adaptor p66shc (2013) (0)
Causes and prevention of sudden cardiac death: ECG, electroanatomical mapping, fibrosis, and channelopathies (2018) (0)
The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts (2018) (0)
The year in arrythmias: real-world data on risk factors, ablation, and genetics. (2019) (0)
Medical Management of Atherosclerosis in Diabetes (2003) (0)
[Degenerative diseases are in the foreground. Interview by Klaus Reinhardt]. (1998) (0)
Chronic coronary syndromes: perfusion pressure, FFR, and secondary prevention. (2020) (0)
Use, complications, and outcome of novel therapeutic interventions. (2016) (0)
Response to letters regarding article, “statins and the risk of cancer after heart transplantation”. (2013) (0)
[The factors of relaxation and contraction produced by the vascular endothelium. Effect of aging and the cardiovascular risk factors]. (1991) (0)
P-274: Activated endothelin system in polyglobulia (2002) (0)
5919Sirtuin 5 deletion confers cerebral protection by attenuating blood brain barrier disruption in mice following middle cerebral artery occlusion (2017) (0)
Controversies in hypertension management: target blood pressure, renal nerve ablation, ARNIs, and NSAIDs medication (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Thomas Felix Lüscher?

Thomas Felix Lüscher is affiliated with the following schools:

Thomas Felix Lüscher's Academic­Influence.com Rankings

Why Is Thomas Felix Lüscher Influential?

Thomas Felix Lüscher's Published Works

Published Works

What Schools Are Affiliated With Thomas Felix Lüscher?

Thomas Felix Lüscher's AcademicInfluence.com Rankings